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ABSTRACT 
Procaccini, Robe rt Louis. Ph.D., University of Rhode Island, 
June , 1972. Glyoxal and Estradiol Mediated Alterations in Rat 
Uterine Histone Acetylation. Major Professor: Dr. David R. DeFanti. 
The immature rat uterus was developed as a model in which to 
measure alterations in his tone acetylation in a target organ following 
hormonal stimulation. The effect of various glyoxal derivatives on 
his tone acetylation and several other parameters was measured in the 
uterine tissue of untreated and estradiol treated animals. Six day 
treatment with glyoxal monohydrate and methylglyoxal-bis-guanyl -
hydrazone (Me thyl-GAG) decreased uterine wet weight and par tially 
blocked e stradiol m.edi ated alterations in uterine vvet weight in animals 
r eceiving concomitant e stradiol and glyoxal treatment. 
The dose dependent in vitro inhibition of uterine histone acetylation 
is thought to oc cur through direct action on the ace tyl ation system.. Th e 
150 values reported for methylglyoxal and phenylglyoxal suggest that the 
dru gs are equally effective as inhibitors of uterine histone acetylation. 
Estradiol mediated alterations in uterine histone acetylation 
were characterized as a r apid depression of enzyme activity; 24 hours 
following horn1onc treatme nt thi s enz yme activity was el8vatcd above 
control l eve l s . The elevation in his tone ace tylation following estradiol 
treatment wa .s bloc ked by eiLli.er methyJglyoxa l or ph'"~nylglyoxal 
administc1·ed 20 hour~ afi:cr est~aciol. Ut.erine \\·c l· \veight, total DNA, 
RNA/DNA and protein/DNA ratios were not affe cted by this treatment. 
These data suggest that histone acetylation may not be of primary 
importance in estradiol stimulation of the rat uterus. 
The phenylglyoxal mediated depressio-n of uterine histone acetyl-
ation preceded the alterations in RNA/DNA and prote in/DNA ratios 
obs erved when phenylglyoxal pretreatment was extended to 48 hours. 
Elevations in total DNA and protein/DNA ratios in the uterus of 
estradiol treated rats were partially suppressed in animals pretreated 
with phenylglyoxal, whereas the RNA/DNA ratio was not affected in 
these animals. 
Results from this study suggest tha t the glyoxal mediated 
blockade of uterine histo ne acetylation ina. y lead to an alteration in 
nucleic acid content of the hormonally stimulated uterus. 
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I. INTRODUCTION 
The biological activity of glyoxal derivatives (ketoaldehydes) 
has been the subject of numerous literature reports. In 1967, 
Szent-Gyorgyi proposed that these compounds may inhibit cell growth . 
Interestingly, methylglyoxal and propylglyoxal were show n to inhibit 
cell division in mouse lymphoma cells (Gregg, 1968). Klamerth (1968) 
suggested that glyoxal may elicit its cellular inhibitory properties at 
the DNA r e plication level. Scaife (1969) has presented evidence that 
\'- ethoxy- o(-ketobutyraldehyde (Kethoxal, Upjohn Pharmaceutical) 
inhibits cell division and protein synthesis . Although kethoxal and 
ano the r ketoaldehyde, methylglyoxal-bis -guanylhyd ra zone , h ave b een 
used therapeutic a lly for l eukemia , the exac t antileukem.ic mechanism 
is not known (Henderson , 1969 ). 
Concomi t antl y, a growing body of obs ervations (A llfrey e t al., 
1963 ; P ogo ct al., 1966, 19 68 ) indicates that histone m e tabolism., in 
particular , his tone acetylation, may b e involved in r egulating DNA 
fun c tion. The i nhibitory action of histone s on cellular processes may 
itself b e regulated, in part, by the acetylation reaction (Gcorgiev , 
1969; Tsanov and Scndov, 1971). It follows that inhibition of histone 
acetylation n1ay l ead to alte rations in ove rall histone function. In 
addilion , pr evious workers have reported (Pogo et al. , 1966 ) alte ra-
tions in hi s tone acetylation follo"ving ho rmonal stimulation. 
As a result, this investigation was designed to study the effects 
of glyoxal derivatives on histone acetylation in a hormonally alterable 
system. 
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ll. LlTERATURESURVEY 
During the past two decades, numerous investigators have tried 
to elucidate the structure, mechanism of action, and general cellular 
function of his tones. Becaus e these low molecular weight, highly 
alkaline proteins are closely associated with deoxyribonucleic acid in 
the nuclear apparatus of cells, early investigators focused their 
attention on the search for proof of a regulatory function involving the 
histones. 
Th'e first hypothesis was pr esented by Stedman ancl Stedman 
(1950) that histones were inhibitors of genetic activity. Later, the 
suggestion was made that the evolution of the structure and funclion of 
various histo ne species parallels, to some degree, the evolution of 
the genes themselves. G eorgiev (1969) stated that histones appeared 
in evolution at the san1e time the cell acquired t wo of its fundamental 
proper ti es: a nuclear n1embrane and the capacity for diffe rentiation. 
DeLange and Smith ( 1971) pointed out thal evolutionary conservatism 
is evident in the structure of his tone s. Histone IV (argini ne -rich), 
with an approximate evolutionary mutation rate of 0. 06 /100 residues/ 
100 niillion years, is 33 tin~es more genetically stable than any known 
prote in. It h as been proposed that the biological function of the 
his tone s dernancls suc h close control of it s structure that even slight 
modifications in its amino acid sequence could not be tolerated 
(Bradbury , 1969). 
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STRUCTURE AND FUNCTION OF HISTONES 
Approximately 15 percent of the nuclea r component of eukaryotic 
cells is composed of his tone protein. The hi stones are beli eve d to 
exist in five distinct fractions: fl, lysine-ri-ch; f2b, moderately 
lysine-rich; and f2al, f2a2, and £3, arginine -ri ch histones. Each of 
the fractions is thought to comprise 20 percent of the whole histone 
(Richards and Pardon, 1970). Virtually all of the deoxyribonucleic 
acid (DNA) in the nucleus exists as a complex with histones. It is 
generally beli e ved that his tones attach to DNA through electrostatic 
linkages. Of these, the strongest are ionic linkages betwee n the 
phosphate groups of the DNA and the basic r e sidues lysine (f ammonium) , 
arginine (guanidinium), and histidine (Richards and Pardon , 1970; 
Lewin, 1970). Combard and V enduly (1970) presented evidence 
indicating that different histone fractions interact wi th DNA at different 
sites on the DNA molecule. They found lysi ne -rich histones in 
associ ati on with DNA in regions of r e latively high adenine-thymine bas e 
content , where as a!ginine -rich hi stones we re foun d in association wi th 
guanine and cytosine -rich regions. 
Not all the his tone fractions affect the activity of the DNA 
complex to the same extent; for ex:am.ple , ly sine -ri ch his tone (£1) 
inhibits the DNA-dependent-RNA polyrneras e r eaction to a l esser 
extent than does the arginine-rich histone (£3). Further, prior acetyl-
ation of uterine histone m .arkedly depresses the inhibitory effect of 
his tones on in vitro RNA synthesis (Teng and Hamilton, 1969). The 
inhibitory effect of arginine-rich histone fractions on DNA dependent-
RNA polymerase is thought to be related to the thiol/disulfide ratio of 
the fraction. Hilton and Stockton (1966) found that diffuse, active 
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chromatin has a greate r proportion of sulfur residues as free thiol 
groups than does dense, inactive chromatin. Purified f3 histone was 
annealed with DNA, and purified RNA polymerase was used to measure 
the efficiency of the treated DNA as a template . When hi stone thiol 
groups were oxidized to the disulfide form before the annealing step, 
his tone -hi stone aggregates we re produced which possessed augmented 
inhibitory prope rties against DNA template activity. These result s 
sugges ted that continuous RNA synthesis in mammalian cells may be 
partly dependent upon the existence of cyste ine -containing histones in 
the ir thiol form (O!'d and Stacken , 1969). 
Extens ive stuclies of his tone metabolism in mammalian cells 
indicate that these prote ins undergo structural alterations by at l eas t 
three enzymatic processes: (1) acetylation (Allfre y ~_!_al., 1964; 
Pogo~ al. , 1966 ; Pogo et al., 1968), (2) mcthylation (Paik and Kim, 
196 9; Paik and Kim., 1971), and (3) phosphorylation (Langan, 1969). 
The enzymatic modification of his tone protein may r epresent an 
early event in the co1nplex process of gene activation for subsequent 
RNA and protein synthesis (Pogo~ al., 1968 ). To support thi s theory , 
s everal n1odel systen1s have b een proposed for the study of hislones 
6 
and their enzymatic modification during periods of increased growth 
b elieved to involve enhanced genetic activity. 
Incorporation studies have established that transformation 
(activation) of human lymphocytes by phytohemagglutinin involves an 
increase in RNA synthesis (Rubin and Cooper, 1963) and in protein 
synthesis (Bach and Hirschorn, 1963), using uridine-2- 14c and 
alanine -l- 14c, respectively. Increased histone acetylation seen in 
response to phytohemagglutinin preceded the increase in RNA and 
protein synthesis; at the same time, cells not stimulated by phyto -
hemagglutinin did not demonstrate this increase in acetylation of their 
his tones (Pogo et al. , 1966 ). 
Pogo~ al. (19 68) , studying rat live r r egenerati on, showed that 
3 turnover of H-acetyl groups incorporated into histones decreased in 
partially hepatectomized rats. Rates of 3H-UMP incorporation i nto 
itNA r each ed maximum leve ls only after histone acetylation had peaked. 
Pogo ( 196 9) found that nucleolar activation in this system began at 2 
hours and chromatin activation at about 6 to 8 hou1·s after partial 
hep a tectomy. He also found tha t ar ginine- rich (f2 al ) histones were 
highly and r apidly acetylated. When the acetylated histones were 
treated with 2M hydroxylamine for one hour, all the l abeled a cetate was 
found to be r esistant to cleavage fro1n his tone. Si nce hydroxyl amine , 
under t hese conditions , will hydrolyze 0-acetyl but not N-acetyl 
linkages, and since, under si1nilar condi t ions , the histone fraction f3 
(arginine-rich) lost 55 percent of its acetyl content, the presence of 
0-acetylated groups was indicated. Verifications of the presence of 
radioactive acetyl groups was accomplished by acid hydrolysis and 
steam distillation of volatile acetic acid. 
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An extensive study by Paik and Kim (1971) has shown that at 
least three enzymes found in the cytosol fraction of calf thymus are 
capable of methylating histones. Protein methylase I(S-adenosyl-L-
me thionine: protein-arginine me thyltransferase) methylate s the 
guanido group of arginine residue s in histones yielding a product 
identified as W -N -methylarginine. When protein methylase I was 
m easu red in rapidly growing h epatoma , the enzyme activity was fo und 
to increa se by 50 to 100 percent (Paik~ al., in press). Kaye and 
She ratyky ( 1969 ) obtained an enzyme preparation from the 105, 000 x g 
supe rnatant fraction of rat or gans which they found c apable of trans -
fer ring methyl groups fro1n S- adcnasyl-L -me thionine and acetyl groups 
fro1n acetyl-COA to arginyl and lysyl residues in histone s. The most 
effective acceptors were unfractionated histones of rat organs, calf 
thymus arginine -rich hi stones and poly-L-arginine . 
An enzyme systen1 derive d from r at brain nucle i selectively 
catalyzed the acetylation of histoncs , using acetyl-COA as acetate 
dono r (Bondy~ a l., 1970 ). The preparation \Vas most active in acetyl-
ati ng arginine-rich histones . Histone acetylase prepare d fro1n nucle i 
of adult rat brains exhibited greater activity than did similar 
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preparations obtained fron~ the brains of newborn rats. In contrast, 
brain cytoplasmic enzyme was low in both specificity and activity. 
Treatment of cerebral chromatin with a solubilized acetylase prepara-
tion augmented the template activity of the treated chromatin for RNA 
synthesis . 
Non-enz.ymatic acetylation of histones has b een reported by Paik 
~al. (1970); howe v e r, the reaction occurs almost exclusively in 
nuclei and has a pH maximum of 10. 0. 
!moue and Fujimoto ( 1969) report a hi stone deacetylating enz yme 
pre sent in calf thymus extracts . The significance of this enzyme in 
biological systems , however, is not known. 
It is evident from these studies that histone modification is an 
active process occur ring most significantly during periods of enhanced 
cell growth . Measurement in several sys terns indicates that histone 
modific a tion, particu l ar ly acetylation, precedes or accompanies 
increases in DNA-dependent-RNA polymerase activity and RNA 
synthesis in stimulated cells (Wilhe l m and McCarthy , 1 970) . However, 
neither direct proof for the involvernent of histones nor their modifica-
tion in the control of RNA synthesis is yet available (Georgiev , 1969; 
De Lange and Smith, 197 1). 
HISTONES AND NUCLEAR MECHANISMS 
Butler (19 66 ) proposed a mechanism for the r egul ation o f gene 
activity involving an interaction between hormone , t arget protein, and 
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histone. According to his model, the hormone, upon reaching its target 
organ, would be spe cifically and p refe rentially bound to a targe t cell 
prote in with subs e quent formation of a protein-hormone complex. 
This complex would then attach or some how inte r a ct with DNA-asso-
ciated his tone and either remove the his tone from the nucleo prote in 
complex or diminish the degree of binding betwee.n DNA and his tone. 
The no w de repress ed DNA segme nt w ould be fre e to take part in nuclea r 
transcriptional functions. This model b e comes most plausible when 
vie we d in light of recent findings that various steroid hormone s are 
c apable of increasing DNA template activity, RNA synthesis , and 
protein synthesis in their respecti ve targe t or gans (Hamilton , 1968; 
Kenney et al. , 1968; Avda lovic and Kochakian, 19 6 9). The biological 
activity of at l east one ster oid hormone , es tradiol - 17-~, is b elieved 
to b e initiated by t he attachment of hor mone to a cytoplasmic "rece ptor" 
protein, followed by translocation of the hormone -protein complex 
into the cell nucleus (Jensen~ al. , 1968 ; M uelle r, 1971; Truong and 
Bauli eu , 1971). ~he early actions of this hormone on i ntac t i mmature 
and ovari ectomized rat uterus i s we ll documented {Teng and Hamilton, 
1969; Bresnich , 1 971 ; and ·Mueller , 197 1). It is generally accepted 
that the action of estradiol on its t arge t organ i nvolves , i n part, an 
activati on of nuclear mechanisms for genetic expre s sio.n (Mue lle r , 
1971). E str adiol may directly affec t the t emplate activity of uterine 
de o xyr ibonucleopr otein , which is firn1ly attached to RNA po lyn1erase . 
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This action is thought to explain the obs e rved increas e in RNA synthesis 
without an apparent increase in RNA polymeras e following estradiol 
a dministration (Gorski ~al., 1965). 
-From 0-24 hours follo w ing estradiol treatment, synthesis of 
uterine histones remain unchanged. However, at 12-24 hours follow ing 
hormone treatment, the rate of chromatin-directed RNA synthesis in 
vitro decreases, whereas RNA l evels increase during the latter stages 
of estrogen action. From thes e ob servations , Gorski ~al. (1965) 
suggest that estradiol may alter the metabolism of ute rine RNA. 
Teng and Hamilton (1969), investigating the involvement of 
his tones in es trogeni c action recently demonstrated that uterine hi stones, 
particularly arginine -rich fractions, ar e capable of inhibiti ng uterine 
chromatin-directe d RNA synthesis , in vitro. In vivo stimulation of 
template activity by estradiol-protected RNA synthesis in vitr.2 from 
the inhibitory effects of added his tone. Estradiol , added in vitro at 
fin a l concentrations of 10- 5 - l0- 6 M, did not protect uterine 
chromatin-directe d RNA synthesis from inhibiti on by the histones . 
The amount of arginine - rich hi stones in association w ith uterine 
chromatin decreases duririg the first hour of estradiol aclminist ralion 
(Barker, 1971). It is not knovvn whether the his tones are n~etabolizecl 
through protolysis or are complexed with non-histone protein. The 
pr esence of a specific enzy me capable of degrading histones (histone 
hydrolase ) has b ee n r eported in an amphibian system (Paik , 1971 ). 
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Libby (1968) reported the presence of a soluble enzyme present 
in inunature rat uterus, which is capable of acetylating his tone. In 
this study, addition of estradiol in vitro stimulated histone acetylation. 
The ability of estradiol to stimulate histone acetylation in vivo during 
the first 15 minutes of hormone treatment has been demonstrated by 
Libby (1971) . Howeve r, Anderson and Gorski (1971) reported that, 
after introduction of estradiol, histone acetylation was at first depress e d 
but then rose, beginning at about 12 hours and elevating above control 
levels at 24 hours following hormone treatment. In their studies with 
protein methyla se, Kaye and She ratzky (1969) found that estradiol-1 7 -
~. preincub a ted with a 150, 000 x g supernatant fraction of imma tur e 
rat ute rus a nd then added to a standard as say, dee reased the methyl-
ation of histone by 10 p e rcent. Furthe rmor e , estradiol-17- 0, 
administered 50 pg/r a t, subcutane ous ly, for 3 d ays decreas ed histone 
methylation by 50 p ercent, measured in vitro. 
Steroid hormones are c apabl e of dir ec t attachment to histones 
both in vitro and in vivo (Sluyser , 1966; Sunago and Koide, 1967; 
Sluys e r, 1970). The greatest extent of hormonal i nte raclion w ith 
histones o ccurs with arginine-rich histone fractions. The effects of 
such interactions could be considerable, since histone attachment to 
DNA rn.ay involve ly syl and arginyl histone residues (Le\vin , 1970). 
The in teraction behveen cortisol -1, 2-t and histones is thought to 
b e dependent on th e presence of 21-dchydrocorlisol , a co ntaminant in 
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most corticosteroid preparations and the possible active metabolite of 
cortisol in vivo (DeLange and Smith, 1971). In studies p e rformed by 
Mande r and Walker (1970), cortisol and 21-dehydrocortisol, a steroid 
with a glyoxal moiety in its structure, reacte d with all histone fractions 
tested in vitro. However, both steroids were bound most extensively 
to arginine-rich histones. Blockade of arginyl histone residues by 
gloxylation (Freedman~ al., 1968) greatly diminished binding of 
21-dehydrocortisol and eliminated binding of cortisol to the histones. 
In addition, the results indicate tha t corticosteroid binding to histones 
may r e quire prior oxidation of the ste roid. The actual binding site 
may involve covalent inte ractions b e tween the steroids and residues of 
the basic amino acids, arginine and lysine, in hi stone protein. 
Howe v e r, the biological significance of these interactions has not been 
assess ed . 
GLYOXALS AND THEIR CELLULAR MECHANISMS 
Glyoxals ar e ke toaldehydes clos e ly related to trio ses and other 
basic metabolites . They reportedly exist endogenous ly in high con-
cent rations (S zent -Gyor gyi , 196 7). Examples of endogenous metabolism 
leading to the formation of glyoxals include glycine to m e thylglyoxal 
and ascorbic acid oxidation to d eh ydroascorbat" (Edgar , 19 69 ). The 
latter compound contains a glyoxal inoiety in its structure and 
reportedly possesses antitumor prope rties (Edgar , 19 69). Methyl-
glyoxal is rn.e tabolize d to lactic acid by h v o closdy related enzymes , 
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glyoxylase I and glyoxylase II (French and Freelander, 1958). Vince 
and Wass (1969) are exploring the possibility of inhibiting the glyoxyl-
ase system in order to potentiate the carcinostatic activity of 
methylglyoxal. 
Szent -Gyorgyi (1968) has proposed that endogenous inhibitors of 
cell division may include molecular spe cies containing a glyoxal 
0 0 
II II 
group (R - C - C - H). In advance of this proposal, Szent-Gyorgyi 
stated that cells possess an unlimited source of meta bolically 
available electrons but are deficient in electron acceptors. Sulfhydryl 
groups involved in the complex mechanisms of cell proliferation and 
prote in syn thes is would exist in their thiol form and could b e oxidized 
to the disulfide form by glyoxals and thereby b e inactivated . In 
subsequent studies, the glyoxals, particularly methylglyoxal and 
propylglyoxal, inhibited cell division in both bacterial and mammali an 
cells (ascites tumor} at concentrations of l0- 3M (Egyud and S zent -
Gyorgyi, 1966). Incorporation studies demonstrated that, although 
prote in synthesis was blocked to a greater extent , both DNA and RNA 
synthesis was inhibited by the glyoxals (Egyud and S zent -Gyor gyi , 1966). 
Methylglyoxal and propylglyoxal i nhibi t cell division i n mouse 
lymphoma (L-5 l 78Y) by t heir ability to block protein synthesis (Greg g , 
1968), whereas glyoxal inhibits DNA synthesis as \.vell as protein 
synthesis in human fibroblasts (Klamerth , 19 68) . Scaife (19 69 ) 
measured 3H-uridinc incorporation into RNA and 3H-thyrnidine 
incorporation into DNA in human kidney cells grown in monolayer 
culture and treated with methylglyoxal or Kethoxal ( 0-ethoxy-o<-
ket·-0-butyraldehyde). Although DNA, RNA, and protein synthesis 
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were inhibited, the most pronounced effe c t of these compounds was the 
blockade of DNA and protein synthesis. 
Procaccini ~al. (1971) used a soluble rat uterine enzyme to 
study the inhibition by methylglyoxal and phenylglyoxal of histone 
acetylation in an i n vitro system. They postulated that, if such an 
inhibitory effect is accomplished in vivo, it might offer an alternate./ 
additional explanation to the known inhibitory properties of the glyoxals 
on cell division and proliferation. 
Interestingly, two glyoxal derivatives, methylglyoxal-bis-
guanylhydrazone (Methyl-GAG) and Kethoxal have found limited use in 
the treatment of leukemia (Freireich ~al., 1962; French and 
F reelander, 1958). However, the exact mechanism of action of these 
drugs is not yet known (Henderson, 1969). 
III . EXPERIMENT AL 
A. ANIMALS 
Immature (22-30 day old) female rats (Sprague -Dawley strain; 
Charles River Breeding Laboratories , Wilmington, Massachusetts) 
were housed in quarters maintained at 70°C supplied with 12-hour 
a lternating c y-cle of light and dark. Animals we re offered food 
(Purina Rat Chow, Ralston Purina Company , S t. Louis, Missouri ) 
and water , ad libitum . However, food was removed 24 h o urs prior 
to sacrifice in the case of 24 - hour time-course studies . 
B . SUBCELLULAR FRACTIONATION AND LOCALIZATION OF 
HISTONE ACETYLATING ACTIVITY: SPECIFIC ACTIVITY 
Eight immatur e (25 day old) female rats were sacrificed by 
cervical dislocation. The uterin e tissue wa s cleaned of connec tive 
tissue , in situ, excised , blotted and weighed . The pooled tis sues 
"ve re hon~ogenized in 9 volumes of 0. 25M cold sucrose solution using 
a Tri-R homogenizer (Tri-R-Instrurn.ents , Rockville C ent r e , N ew York). 
The homa ge nate d were pooled, sepa rated into 15 ml Nalgene centrifuge 
tubes and centrifuged at 780 x g (2, 500 RPM) for 10 minutes at o0 c in 
a S ervall r efrige rated centrifuge (Sorvall , Inc., Norwalk, Connec ticut). 
The supernatant was tr ansfer r ed to another s et of tubes and c entri-
fuged at 10, 000 x g (9, 500 RPM) for 15 minutes. The nnclear fraction 
was resuspende d to volun1e in 0. 25M sucrose solution and centrifuged 
16 
as before. The resultant supernatant was decanted and discarded, the 
nuclear pellet was resuspended to' volume with Robinson's media 
(Robinson, 1949), placed in glass screw-cap vials and frozen at -40°C 
until required for assay. The 10, 000 x g supernatant fraction was 
transferr ed to straight-walled plastic centrifuge tubes, capped and 
centrifuged at 105, 000 x g (32, 000 RPM) for 1 hour at o0 c in an IEC 
Pre pa ration Ultracentrifuge (Model B -60, International Equipment 
Company , Needham Heights, Massachusetts) equipped with an A-170 
aluminum h ead . The mitochondrial fraction was resuspe nded to 
volume in 0. 25 M sucrose solution and centrifuge d at 10, 000 x g as 
before. The resultant supe rnatant was discarded. The mitochondrial 
fraction was re suspended to volume in Robinson's media, transfc r red 
to screw-cap vials and stor ed at -40°C until requir ed for assay . The 
105, 000 x g supernatant fraction was tr ansferred to storage vial s and 
frozen as above . The microsomes were was h ed twice with 0. 25M 
sucrose solution, resuspended to volume in Robinson's media, and 
stored at -40°C until needed for assay. An aliquot of the thawed 
fraction requir ed for assay of histone acetylation activity was used for 
protein detern1inations on ·all subcellular fractions. 
C. IN VITRO S TUDIES 
1. Tern.perature study : Deternrination of t e 1nperature coefficient 
(Q10). Components of the con.1.plete assay syste1n previously described 
were incubated in a Dubnoff metabolic incubator shaker (Dubnoff , 
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Precision Scientific Company, Chicago, Illinoi s ) s e t at 30 , 37°, 40°, 
45°, 50°, 55°, and 60°C for 30 minutes. Histone acetylating activity 
at the various t emperatures was determined. These data were 
inserted into the van't Hoff equation to dete rmine the Q10 value: 
log QlO 10 log kz = 
tz - t1 k1 
where: kz - r eaction rate at temperature tz -
and k1 = reaction rate at temperature t 1 
2. Dose response for methyl- and phenylglyoxal : de t e rmination 
of 150. Phenyl glyoxal (Pfalz and B aue r) and me thylglyoxal (Aldrich 
Chemical) were dissolved in 0. 5 M phosphate buffe r, pH 7. 7 prior to 
use. Various concentra tions of drug s we r e pr e incub ated in the 
presence of enzyme in the assay m edj um at 37°C for 15 minutes; 
his tone was added , and the r eac tion was allowe d to p roceed for an 
additio nal 30 minutes . The d ata we re plotted (% inhibitio n vs . dru g 
concentration), and the 150 v a lue (d rug concentration at which 50 pe rcent 
inhibition is ob served ) was d e l e r mined graphically . 
3. Effec t of enzyme -d rug_ and hi stone -drug preincubatio r, o_:r:_~~~tone 
ace tyl ation. (a ) Enzyrn.e - D rug : Phe nylglyoxal was dis sol ved in 0. 0 5 M 
phosphate buffer pH 7. 7, to a concentration of 10-2 M . Fron1 this stock 
solutio n , serial dilutions of 1 o- 3 M and 10 - 4 M phenyl glyoxal we re 
pr e p ared . A 0. 25 n1l aliquot of each concent ra tio n of phenylglyoxal 
was tr ansfer r ed to each of three tubes cont aining 0. 25 ml of l 0, 000 x g 
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uterine supernatant fraction in concentrations of 5 x l0- 3 M, 5 x 10- 4 M, 
and 5 x 10- 5 M phenylglyoxal, respectively. The contents of the tubes 
were mixed and incubated at 3 7°C. At the end of a 10 minute pre -
incubation period, a 0. 1 ml aliquot of each mixture was transferred to 
tubes containing all components of the standard assay system with 
exception of uterine supernatant. The tube contents were mixed and 
incubated , with shaking, for 2 0 minutes at 3 ?°C. Uterine supernatant, 
preincubated with phosphate buffer constituted the control samples. 
Standard procedures for the detennination of hi stone acetylation activity 
were performed on each sample. 
(b) Histone-Drug: Solutions of phenylglyoxal at concentrations of 
10-2 M, lo- 3 M and lo-4 M were prepared as before. A 0. 6 ml aliquot 
of a freshly prepared solution of calf thymus histone (10 mg/ml) was 
added to tub e s containing 0. 6 ml of phenylglyoxal solution at various 
concentrations spe cified. The resultant mixtures, containing phenyl-
glyoxal at concentrations of 5 x lo- 3 M, 5 x 10-1 M and 5 x lo-5 M, 
respectively, were incubated, with shaking, for 10 minutes at 37°C. 
Following this period, a 0. 2 ml aliquot containing 1. 0 mg of hi stone 
requir ed for assay was tr a.nsfc r red to tubes containing all components 
of the assay system. wi th the exception of his tone . The completed 
mixtur e was then incubated for an additional 20 rn.inutes at 37°C with 
shaking. H is tone, preincubated with buffer , cons titutecl the controls. 
Assay of h is tone acetylating activity of the various samples '.vas 
accomplishe d as above. 
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D. IN VIVO STUDIES 
1. Tissue Weight: Alterations with Estradiol and Glyoxals. 
Immature female rats (26 days old}, weighing 70-90 grams, were 
divided into groups of five animals each. Groups were housed in 
plastic box cages furnished with wood chip bedding. Animals were 
allowed food and water ad libitum. Solutions of drugs in 0. OSM phos -
phate buffer (pH 7. 4) we re prepared fresh daily and administered 
according to the following schedule: 
(1) phosphate buffer, 1 ml/kg, intraperitoneally, for 6 days, 
plus 0. 2 ml saline subcutaneously, every 12 hours for 60 
hours, starting on day 3 of schedule. 
(2) phosphate buffer, 1 ml/kg, intraperitoneally, for 6 days, 
plus estradiol-17- ~ dipropionate (Mann Resec:uch Labs} 0. 2 ml 
(12 ug) subcutaneously, every 12 hours for 60 hours, starting 
on day 3 of schedule. 
(3) glyoxal monohydrate, 200 mg/kg, intraperitoneally, daily 
for 6 days. 
(4) glyoxal monohydrate, 200 mg/kg, intraperitoneally, daily 
for 6 days, plus estradiol, 0. 2 ml, subcutaneously, every 12 
hours for 60 hours, starting on day 3 of schedule. 
(5) methylglyoxal-guanylhydrazone (methyl-GAG, Aldrich 
Chemical) 20 mg/kg, intraperitoneally, daily for 6 days. 
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(6) methylglyoxal-guanylhydrazone, 20 mg/kg, intraperitoneally, 
daily for 6 days, plus estradiol, 0. 2 ml, subcutaneously, every 
12 hours for 60 hours, starting on day 3 of schedule. 
Rats were sacrificed by cervical dislocation. The liver of each 
animal was perfused in situ with cold 0. 25 M sucrose solution, removed, 
weighed, and placed on ice. The uterus was surgically cleane d of 
connective tissue, excised, press blotted and weighed. The liver and 
uterus from e ach animal was homogenized separately in 9 volumes of 
Robins on 1 s medium (Robinson, 1949), using a Polytron homogenize r 
(Spe e d #6 for 15 s e c.), followe d by centrifugation at 10, 000 x g 
(9, 500 RPM) for 10 minutes at o0 c in a Se rva ll Refrigerated C entrifuge 
(So rval, Model RC2 - B ). The sup e rnatant fraction of liver and uterus 
was transferred in 1. 0 ml aliquots to 5 ml glass screw-cap vials and 
sto red at -40°C u nti l r equired for enzymatic assay. 
2. Es tradiol and Phenyl glyoxal: I ni tial response . A stock 
solution of es tradiol-1 7 - f.> (Scwartz-Mann) was p repared by dis solving 
25 mg of the hormone in 100 ml of 95% ethyl alcohol. At the time of 
administration , 1. 0 m l of e thanolic stock solution was slowly added to 
3. 0 ml of saline w ith con.s t .ant slirring t o prepare a suspens ion con-
taining 60 p g /ml of estradiol. At th e time of inj ec tio n (treatment 2) 
each rat r eceived approximate ly 12 p g of es tr acliol (0. 2 ml ) s ubcu-
taneous ly. A freshly pr epa r e d solution of phenylglyoxal rnonohydrate 
in 0. OSM phosphale buffer was adjusted to pH 7. 4 v:ith 0. SN NaOH . 
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Four groups of eight, 26-day old female rats were administered phenyl-
glyoxal, 250 mg/kg, intraperitoneally (Treatment 1). At the end of 
one hour, each animal received e stradiol, 12 pg I rat, subcutaneously 
(Treatment 2). Groups receiving estradiol, following phenylglyoxal 
pretreatment or estradiol alone, were sacrificed at 0, 5, 10, and 15 
minutes following estradiol treatment. Control animals receiving 
1 ml/kg of 0. 05M phosphate buffer alone were sacrificed one hour 
following injection. Rats were sacrificed by cervical dislocation. 
Individual uterine tissue was press blotted, and weighed , and the 
pooled tis sues from two identically treated animals were homogenized 
in 9 volumes of cold Robinson's media. The 10, 000 x g supernatant 
fractions were stored at -40°C in 5 ml glass screw-cap vials until 
required for assay. Protein determinations of the supernatant fractions 
obtained from experimental groups were carried out by the method of 
Lowry ~al. (1951 ). Students "t" test was employed to dete rm.ine 
statistical differences between treated and untreated groups. 
3. Activity of Estradiol and Glyoxals: Time response. 
Immature (25 day old) female rats were divided into groups of 6 to 8 
animals. Control groups received 1 ml/kg of the drug vehicle, 0. 05 M 
phosphate buffer (pH 7. 4) or estradiol vehicle . Rats were administered 
either estradiol-17- ~. 10 ug/rat, intraperitoneally, or phenylglyoxal, 
250 mg/kg, intraperitoneally. Animals treated with either drug were 
sacrificed at 1, 2, 4, 8, 16, and 24 hours follo\.ving drug adm.inistration. 
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Rats were sacrificed by cervical dislocation. The uterine tissue was 
surgically cleaned , blotted and weighed. For histone acetylation 
studies, tissue s from two rats we re pooled and homogenized in 9 
volumes of Robinso n' s m edia. Furthe r preparation and storage of the 
uteri~e extract for subsequent analysis of his tone acetylation activity 
was as described previously. 
4. Drug Interaction: Estradiol and Glyoxals. Thirty day old 
female rats were divided into groups of 8 to 10 animals. Rats we re 
administered estradiol , 10 ug/rat, intraperitoneally. Control animals 
received estradiol vehicle as described previously. At 2-0 hours 
following hormone treatment, estradiol freated rats received either 
methylglyoxal (125 mg/kg or 250 mg/kg) or phenylglyoxal (250 mg/kg), 
intrape ritoneally. Vehicle treated rats also received the same doses 
of the glyoxals. Control rats received 1 ml/kg of the drug vehicle, 
0. 05 M phosphate buffer (pH 7. 4). Groups of animals were inj~cted 
at appropriate intervals in order to account for .the time_ required for . 
sacrifice of each group. All animals were sacrificed 2.-4 hours after 
estradiol administration (4 hours following glyoxal a:dministration). 
Protocol followed after sacrifice, involving weig_hing, uterine 
extract preparation and assay were as described previously except 
that tissues from this study were not pooled . Protein determinations -
were carried out by the m ethod of Lowry~ al. (1951). 
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E. ASSAY OF HISTONE ACETYLATION 
The procedure for the analysis of histone acetylation is a mod-
ification of the method of Libby (1968). A 0. OS ml aliquot of a 10, 000 
x g supernatant fraction of rat uterus (prepared as previously des cribed) 
capable of acetylating histones was routinely employed as the enzyme 
source in the assay system. The assay mixture contained, in addition 
to the supernatant fraction, 100 umoles of phosphate buffer (pH 7. 7), 
S umoles ATP (Sigma Chemical Company) solution adjusted to neutral-
ity with 0. SN NaOH, 0. OS umolcs co enzyme A (Cal-Biochem), Su C 
Na-acetate -l- 14c (New England Nuclear; specific activities of S7-60 
millicurie s /millimole ); and 1. 0 mg calf thymus his tone (Worthington 
Biochemicals and enough distilled water to make a final volume of 1. 0 
ml. Components of the incubation mixture were pipet ted into lS ml 
Nalgene tubes. All drug preparations were made in the buffer used for 
enzyme incubations. Incub ations were carri ed out in a Dubnoff metabolic 
0 
shaker at 37 C under air . Following the pr es cribed incuba tion tin1.e, the 
reaclion \vas terminated by the addition of S m l of cold acetone. The 
tubes were seale d with Parafiln1. (American Can Company, Nee nan, 
Wis cons in), mixed by inversion and allowed to stand in a freezer at 
-40°C for approx imate ly 30 minutes. The tubes we re then centrifuged 
for 10 minules at 10, 000 x gin a Sorval Model RC2-B refrigerated 
centrifuge at 0°C. The re sultanl aqueous -acetone supernatant was 
de canted and discarded and lhe tubes inverled and allowed to 
dry. Drying was usually con1.pl e te in 30 - 40 minutes . The 
precipitate was resuspended in 1. 0 ml of 0. 2N H 2so4 by mixing in a 
Vortex mixer for 10 seconds, and the tube s were allowe d to stand at 
room t e mperature for 2 0 minutes. The tubes were then centrifuged 
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at 10, 000 x g for 10 minutes and the resultant superna tant was care fully 
decanted into another set of Nalgene tubes. After the addition of 5 ml 
of cold acetone, the tubes were mixed by inversion, as before, and 
allowed to stand in a freezer for approximately 30 minutes. The tubes 
were centrifuge d for 10 :minute s at 10, 000 x g and the supe rnatant 
discarded. One ml of O. 05 M barbital buffer, 7. 5 Min urea (pH 9. 0), 
was added to the precipi tate and mixed on a Vortex mixer for 10 s ec onds. 
The tube s were allowed to stand at room te m p e ratur e for 15-20 minutes 
at which time 0. 5 ml of this solution was tr ansfe rred to glass counting 
vials containing 15 ml o f a sci n ti llation cocktail which was prepared by 
dissolving 4g of 2-5-diphenyloxazole (PPO) plu s 50 mg of 1,4-phenyl-
ene -bio - 2 -(5 -phenyloxaz ole ) in 700 ml of toluene plu s 300 m l of BBS-3 
(Bio-Soiv , Beckman Instruments , Inc . ). Th e vial s were counted i n a 
Packard Tri-Carb Liquid Scinti ll ation Spectrorneter at a counting 
efficiency of approximatel y 70 %, as determined by quench correc tion 
s eries . 
F. PROTEIN DETERMINATION 
Pro te i n content of whol e hon~ogenate , subcellular fractions and 
10, 000 ·x g supernatant was delcrnunc<l by the inethod of Lowry et a l. 
(19 5 1). A 0. 2 ml sample of the fraction to b e as sa ye<l was ad<le<l to 
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tubes containing 0. 8 ml of 0. 5N NaOH. Prote in standards at concen-
trations of 0. 5, 1. 0 and 1. 5 mg/ml were pre pared using bovine plasma 
albumin (Calbiochem). Reagent blanks containing 0. 2 ml of Robinson's 
m e dia were treate d identically as tissue samples. The tubes were 
stoppered and placed in a hot water bath for 1 hour maintained at 
70-75°C. The samples were cooled by imme rsion in cold tap water . A 
0. 2 ml aliquot of the boiled sample was added to 0. 8 ml of 0. 5N NaOH 
a 
and 5. 0 ml of Reagent A . The sample s were mixed on a Vortex mixer 
and allowed to stand for 20 minutes at room tempe rature. Following 
b 
this, 0. 5 ml of Reag e nt B was added to each sample, mixed 
immedia t e ly and allowed to stand at room temp e ratur e for 40 minutes , 
until color development was complete . The absorbance at 500 nm was 
re a d against the r eagent blank o n a Beckman DB -Spectrophotometer 
(Beckman Instruments ). 
G. EXTRACTION OF NUCLEIC ACIDS 
The method of Schneider ( 1945 ) for the extraction of nucleic acids 
and the measurement of DNA was used. 
aReagent A: 2. 5 m l of a 2. 7% (w / v) potassium. tartrate solution 
and 2. 5 ml of a 1. 0% (w /v) coppe r sulfate added to 2 5 0 ml of 2 . 0% 
(\v /v) sodium carbonate solution. 
bReagent B: Conunercial folin-phc nol reagenl dilute d to IN 
with distilled water. 
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A 0. 7 ml aliquot of a 10 percent rat uterine whole homogenate was 
mixed (Vortex) with 2. 5 ml cold 10 percent trichloracetic acid (TCA) in 
15 ml Corex glass tube and centrifuged in an IEC Clinical Centrifuge at 
1000 RPM for six minutes. The supernatant was decanted and discarded 
and the precipitate resuspended in 2. 5 ml of cold 10 percent TCA. The 
tubes were centrifuged as above, and the supernatant was decanted and 
discarde d. This procedure is used to remove acid-soluble phosphorus 
compounds. 
The tissue residue was suspended in 1. 0 ml of distilled water by 
Vortex mix for 10 seconds, and 4 . 0 ml of 95 percent ethyl alcohol and 
centrifuged . The supernatant was decanted and discarded, and the 
residue was r e suspende d in 5. 0 ml of 95 percent ETOH. The super-
n a tant was decanted and discarded. Thes e steps are used to remove 
traces of TCA from the r esidue . 
The tissue residue was boiled 3 times for 3 ininutes each with 5 . 0 
ml portions of an alcohol-ether mixture (3:1). A small boiling chip was 
added to each tube in orde r to facilitate even boiling. The tubes were 
centrifuged as before following each boiling and the supernatant was 
decanted and discarded. This procedure was employed to remove phos -
pholipi ds . 
The ti ssue residue was suspe nded in 1. 3 ml of distilled .water 
nrixed with 1. 3 ml cold 10 percent TCA and centrifuged. The supcrnate 
was decanted and discarded. 
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The tissue residue was resuspended in 5. 0 ml of 5 percent TCA, 
and the tubes were h e ated for 15 minutes in a water bath at 90°c. The 
tubes were centrifuged and the supe rnatant was decanted and saved. 
The tissue residue was resuspended ir{ 2. 5 ml of 5 pe rcent TCA 
and centrifuge d. The TCA extracts we re combined (7. 5 ml) to form 
the nucleic acid extract. 
H . ESTIMATION OF DNA 
One ml of the nucleic acid extract was mixed with 2. 0 mi of 
diphenylamine reagenta and heated in a boiling water bath for 10 minutes 
at 90°C. The intensity of blue color wa s r ead at 600 nm. 
DNA standard solution·s were prepared in concentrations ranging 
from 20pg/ml to 200pg/ml by dissolving 10 mg of highly polymerized 
DNA in 25 ml of 5 percent TCA, and diluting to the desired concentra-
tions . A reagent blank of 5 percent TCA was us ed . 
I. ESTIMATION OF RNA 
The method of Ceriotti (1955) "\va s us ed for the measurement of 
RNA. 1' ive ml of the nucleic extract was added to 5 . 0 ml of freshly 
prepared orcinol reagentb ~n 15 rn.l screw-cap tubes. The samples were 
aDipheny1amine Reagent: 1 gn.1. of diphenylamine which is recrys-
talli zed in boiling hexane is dissolved in 100 ml of glacial acetic acid 
(analytical reagent) and 2. 75 ml of reagent concentrated sulfuric acid is 
added . 
bor cinol Reagent: 200 mg of purified orcinol is dissolved in con -
centrated HCL, add 10 ml of CuCL2 reagent (0. 00..f.M CuCL2 in concen-
trated HCL: 68. 2 mg CuCL2/lOO ml HCL ) and make up to 100 ml with 
concentrated HCL. 
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mixed thoroughly and the tubes placed in a boiling water bath for 40 
minutes. After cooling 'yVith running water , the color was extracted into 
5. 0 ml of isoamyl alcohol with shaking (B uchler Instrume nts, New Jersey). 
The tubes were centrifuged and a 3. 0 ml aliquot of the isoamyl alcohol 
layer, containing the chromophor, was pipetted into an additional series 
of tubes. The absorbance at 675 nm was determined. RNA standard 
solutions were prepared by dissolving RNA in 5 p e rcent TCA over low 
heat. The isoamyl alcohol layer t aken from the tube containing no RNA 
was used as the blank. 
J. STATISTICAL METHODS 
The 2-tailed students "t'' test for inde pendent means , calculated 
on an Olive tti Underwood Programma 101 desk computer, was used to 
test for differences between means. The formula employed is as 
follows : 
X1 - X2 
t= --------
sp (1/N 1) + (1 /N2) 
where : 2 2 
N1 - · 
N2 = 
s1 2 = 
s 2 = p 
(N l - 1 )S l + (N2 -1 )S2 
N l + N2 - 2 
Co ntrol sample size S2 
2 
Tr eated sample size X1 
Control sample variance X2 
= Treated sample variance 
= Control sa1nple m e an 
= Treated sample rnean 
The degrees of freedom. '''er e taken as N 1 + N2 - 2. The l evel 
of significance (P) was det e rrr1ined by con1parison of "t" with value.:> 
from standard t ables . 
IV. RESULTS 
The 10, 000 x g supernatant fraction of rat uterine tissue was 
employed as the hi stone acetylating system throughout the study 
(Appendix A and B). 
Various concentrations of methylglyoxal and phenylglyoxal were 
preincubated in a standard assay system for 15 minutes . His tone was 
added and the r eac tion was allowed to proce ed for an additional 30 
minutes . Under these conditions, as shown in Figure 1, both phenyl-
glyoxal and methylglyoxal inhibited in vitro his tone acetylation in a 
concentration dependent manner . Drug concent rations of 2 x 10-4 M to 
1 x l0- 3M depressed in vitro histone acetylation approximately 25 
pe rc ent to 75 p e rcent, respectively (Figur e 1). The 150 for methyl -
glyoxal wa s 0. 5 mM, and 0. 4mM for phenylglyoxal (Tabl e 1). 
The in vitro effect of i ncubating phenylglyoxal with the uterine 
his tone acetylation preparation prior to assay is shown in Table 2. 
Following a 10 rninute incubation pe riod, an aliquot of the preincub a tion 
systen1 containing enzyn1e and drug was introduced into a standard 
assay system . The reaction was allowed to proce ed for 20 minutes . 
Under these co ndi tions, approximately 80 percent inhibition was 
achieve d at 5 x io-4M as say system concentration, b e low which l evel 
no significant degree of enzyrne inhibition wa.s noted . The results of a 
parallel study, designed to deterr:nine the effect of phenylglyoxal 
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Figure 1: Effect of (a ) phcnylg lyoxal and (b ) methylglyoxal o n 
in vitro histone acetylation by a cell-free rat uterine 
syste1n . ·Freshly prepared solutions of glyoxals were 
added at various concentrations and preincubatcd for 
15 minutes at 37°C prior to the addition of his tone . 
The r eac lion was a llowed to p roceed for an addilional 
30 minutes . Each point represents at l east three 
d e t e rmina tions. 
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Table 1. Inhibition of in vitro histone acetylation by glyoxal derivatives : 
I ndex of inhibition (I 50 value)a 
C ompound I so Value 
Me thylglyoxal 0. 5mM 
Phenylglyoxal 0 . 4mM 
a The approximate concentration of drug at 
which 50 percent inhibition is observed. 
Various concentrations of inhibitors were 
preincubate d for 15 min at 37°C prior to 
addition of 1 mg calf thymus his tone . 
The data was plotted and I 50 values 
graphically determined. 
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Table 2. In vitro inhibition of histone acetylation: Effect of phenyl-
glyoxal-e nz yme pre incubation 
Phenylglyoxal Concentration (Final) Histone Acetylation 
dpm/mg Histone 
a 
b 
Preincub a tion 
System a 
5 0 lo -3M . x 
5. 0 x 10- 5M 
Assay 
b System 
5 0 lo -4M . x 
5 0 lo -SM . x 
+ J, Mean_ S. E."" 
22, 140 + 300 
+ 4, 902 - 591 
+ 20,117 - 1521 
+ 22, 317 - 1011 
Percent 
Inhibition. 
control 
78 
10 
0 
Phenylglyoxal s olutions of appropriate ·concentrations were incubated 
with 0. 25 ml aliquots of 10, 000 x g rat ute rine supernatant fraction 
at 37°c for 10 min with shaking . 
Following preincubation (a ), a 0. 1 ml aliquot of the phenylglyoxal-
enzym.e mixture (equival ent to 0. 05 ml supernatant ) was added to 
tubes containing 0. 9 ml of standard assay system components , l ess 
sup e rnatant . Th e cornpleted system was then incubated at 37°C , 
with shaking, for 20 min. 
>!<Mean~ S. E . of triplicate determinations . 
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incubation with histone are presented in Table 3 . In this study, a 
S x lo-4 M phenylglyoxal assay system concentration inhibited in vitro 
his tone acetylation by approximately 30 percent. Inhibition of his tone 
acetylation was not evident at a concentrati~n of S x 10-6M phenyl-
glyoxal. 
The effect of gl yoxals on uterine weight and total body weight 
gains in immature rats was explored by administering daily injections 
of me thylg lyoxal-bis -guanylhydrazone (Methyl-GAG , 20 mg /kg , intra-
pe ritoneally) and glyoxal monohydrate (200 mg/kg, intrape ritoneally) 
for six days . The increase in total body weight over the six day 
treatme n t period was also studie d. R e sults of this study are presen ted 
in Table 4. A nimals r e ceiving glyoxal monohydrate gained signifi-
cantly l es s weight (P <.. 0. OS) than di d the contro l animals. Uterine 
wet weight of g lyoxal trea t e d animals wa s approx imate l y SO p e r cent of 
vehicl e tr eat ed controls. Thi s a lte r ati o n was r e flected when the d at a 
was expressed as uterine /body we i ght ratio. This v a lue was em.ployed 
to account for v ariation in tis sue weight that may b e due to body weight 
diffe r ences i n animals fro1n any experimental group . No diffe rence 
(P ) 0. 05) in net body wei ght gain was observed i n animals r ecei ving 
M ethyl-GAG , 20 mg/kg , i ntraperitoneally , fo r six days when com-
p ared to control s. Howeve r, uterine \\·et weight of Methyl-GA G treated 
ani1nals was depressed (P < 0. 025), but to an extent l ess than that 
not e d in the glyoxal t1·eated group. This alteration '-.Vas also r eflected 
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Table 3. In vitro inhibition of his tone acetylation: Effect of phenyl-
glyoxal-histone preincubation 
Phenylglyoxal Concentration (Final) 
Preincubation 
System a 
5.0 x lo- 3M 
5.0 x l0- 4M 
5.0 x 10-5M 
Assay 
Systemb 
5. 0 x 10-4 M 
5. 0 x l0- 5M 
5. 0 x 10- 6M 
Histone Acetylation 
dpm/mg Histone 
Mean± S. E. "~ 
26, 553 ± 3666 
18, 303 ± 4378 
22, 700 ± 1255 
2 6' 7 40 + 1691 
Percent 
Inhibition 
control 
32 
15 
0 
aO. 6 ml his tone solution (10 mg/ml) was added to 0. 6 ml of phenyl-
glyoxal solution of various concentrations, or 0. 6 ml of phenylglyoxal 
v ehicle (phosphate buffer) for control as says and the mixture was 
incubated with shaking for 10 min at 37°C. 
bFollowing pr e incubation period, a 0. 2 ml aliquot of phenylglyoxal-
histone mixture (equivalent to 1 mg histone) was added to lubes 
containing 0. 8 ml of standard assay system components, less 
histone. The complete system was then incubate d at 37°C for an 
additional 20 min. 
>:<Mean ± S. E. of triplicate determinations. 
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Table 4. Effect of glyoxal derivatives on body we ight and uterine wet 
weight in imma ture female rats 
Body Weightb Ute rine We t Uterine /Body 
Increas e (gm) W eight (mg) Ratio (%) 
Treatmenta M e an± S. E. (N) M e an± S. E. (N) Mean± S. E. (N) 
Control 34. 4 ± 3. 1 (5) 152 ± 15 (5) 0.140 ±. 01 4 (5) 
Glyoxal 21.2 ~ 3.6 (4) 68 ± 5 (4) 0. 065 ± . 00 4 (4 ) 
(P < . 05 )'~ J, "' (P < . 001r (P < . 0025)"' 
Methyl-GAG 32. 0 ± 2. 9 (5) 107 ± 8 (5) 0. 092 ~ . 008 (5) 
(P) .05) * J, "' (P < . 025) '" (P < . 01) "' 
aCo n trol: 1 ml/kg, i. p., 0. SM phosphate buffer (pH 7 . 4) daily for 6 
days; Glyoxal: 200 mg/kg , i. p.; and Methylglyoxal-bis-guanyl-
hydrazone (Methyl -GAG), 200 n1g/kg, i. p., daily for 6 days . 
bMean body we ight gain during 6 day experimenta l period. 
"' 
"'Determined by Student ''t" test. 
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in the uterine/body w e ight ratio, indicating that the alteration was not 
due to inherent tissue weight differences attributable to variations in 
total body weight alone. 
In order to determine the effect of prior glyoxal treatment in 
animals receiving estradiol alone, several groups of rats were given 
daily injections of glyox al, 200 mg/kg, intraperitoneally, or Methyl-
GAG, 20 mg/kg, intraperitoneally, for six days. In addition, 
estradiol 12 pg/rat was administered subcutane ously every 12 hours 
for 60 hours beginning day three of treatme n t. The comparison of 
effect of estradiol alone or in animals pretreate d with glyoxals is 
presente d in Table 5. Uterine /body weight r a tios of animals rec e iving 
either glyoxal or Methyl-GAG .prior to estradiol administration were 
significantly lower (P ( 0. 005) than were compa rable values obtai ne d 
from anirnals r ece i ving es tr adi ol alone. No significant differences 
were obs erved in the liver /bo cly weight ratio of anirn.a l s r eceiving 
estradiol alone or in combination with either g lyo xal or Methyl-GAG. 
The early effect of estra<lio l administration on histone ace tylation 
activity i n i mrnat.ure r at uterus was explored by sacrificing group s of 
hor mone treated anir11.al s at 0, 5, 10 and 15 minutes follo\ving inj ection 
of estradiol , 12 µ g/rat , subcutaneously. The soluble uterine histone 
ace tyl a lio n fraclion was subsequently p re par e d (as desc ribe d previous ly) 
and the enzyme activi t y determined (Fi gure 2). In addition , a second 
s e ries of animal s rec eive d phenyl gl yoxal, 250 mg/kg , intraper itoneally, 
1 hour prior to estradiol ad1ninistration , in order t o d ete r rnine the 
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Table 5. Effect of combined glyoxal and Methyl-GAG with estradiol 
administration on uterus /body ratio and liver /body ratio 
in immature female r a ts: Comparison betwee n glyo xal 
pretreated and estradiol treated animals 
Treatmenta 
Estradiol-17-C? 
Glyoxal plus 
Estradiol 
Methyl-GAG plus 
Estradiol 
Uterus /Body Ratio(%) 
Mean~ S. E. (N) 
0. 197 ~ o. 006 (5) 
o. 104 ± 0. 006 (5) 
(P(.005)* 
0. 147 ± 0. 010 (5) 
(P < . 005) >:' 
Liver /Body Ratio(%) 
Mean± S. E. (N) 
5.51:0.21(5) 
6. 17 ± 0. 29 (5) 
(P> .05) * 
5. 09 ± 0. 35 (5) 
(P > . 05 )>:' 
aEstradiol-17-0: 10 pg/r a t, sub. Q., every 12 hrs for 60 hr s 
beginning day 3 of experimental period; Glyoxal monohydrate, 
J, 
200 mg/kg , i. p. d a ily for 6 d a ys plus estradiol, 10 p.g/rat ever y 12 
hrs for 60 hr s beginning day 3 of experimental period; Methyl-
glyoxal-bis-guanylhydraz o ne (Methyl-GAG ), 20 mg/kg , i. p., daily 
for 6 days, plus es tradiol, 12 p g /rat ever y 12 hrs for 60 hrs 
b eginni ng day 3 of experimental p e riod. 
"''Determine d by Student ' ' t" t est. 
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232, 280 ± 30, 490 (4 ) 
.___J 
5 10 15 
TIME AFTER ESTRADIOL (MIN) 
Figure 2: Hi stone acetylation in soluble uterine fraction fro1n 
r ats treated with cstradiol alone and in combination 
with phcnylglyoxal. Rats were administered eilher 
1 ml/kg of 0 . 05M phosphate buffer vehicle (0); 
estracliol, 12 µg/rat , sub--Q, (0--0); or phenylglyoxal, 
250 mk/kg, i. p., for 1 hour follo\.vcd by estradiol 
(~ ) . Rats we re killed at th e tirn.e i ntcrvals 
indicated and soluble uterine enzyme activity measured. 
effect of phenylglyoxal pretreatment on any early hormone-mediated 
alterations in uterine his tone acetylation. Enzyme activity was sig-
nificantly depressed (P <. . 05) when measured 10 and 15 minutes 
following estradiol treatment. A further decrease in enzyme activity 
was noted in animals pretreated with phenylglyoxal one hour prior to 
estradiol administration. The differences seen with estradiol treat-
ment alone were significantly different (P < 0. 05) from phenylglyoxal 
pretreated animals given estradiol for 15 minutes. 
The in vivo effect of estradiol on uterine wet weight and his tone 
acetylation in immature female rats was monitored at 1, 2, 4, 8, 16, 
and 24 hours following hormone treatment. In addition, a parallel 
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study was performed using phenylglyoxal, 250 mg/kg, intraperitoneally, 
in order to determine the time course of the early phenylglyoxal 
mediated decrease in uterine his tone acetylation noted in the previous 
study. The alterations in histone acetylation activity following 
estradiol and phenylglyoxal administration are presented in Figure 3. 
A very rapid estradiol mediated decrease in the ability of the uterine 
enzyme preparation to acetylate his tone was found to occur following 
hormone administration. Enzyme activity remained almost completely 
depressed until 8 hours after estradiol administration , when enzyme 
activity began to increase during an 8 to 12 hour period. During 16 to 
24 hours, the initial effect of the honnone was reversed, so that at 24 
hours post estradiol, enzym.e activity was increased to 135 percent of 
control. 
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F i gure 3 : Alteration of histone acetyl ation by estradiol and phcnyl-
glyoxal. Each point represents the mean of at l east .,.. 
three values , each obt a ined fro1n the pooled tis sue of two 
animal s . Enzyme activity of control animals is expressed 
a s Dpm / mg protein/30 min. (()--0 ) cstradiol , 10 pg/ rat , 
i . p . ; ( ~ ) phenylglyoxal, 250 mg/kg, i. p . 
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Enzyme activity response to phenylglyoxal administration closely 
follow e d the response seen with estradiol. Uterine enzyme activity 
decreased rapidly, although not as marke dly as note d follo wing 
estradiol treatment. Reversal of . the phe nylglyoxal mediated depress-
ion in enzyme activity began 4 to 8 hours following drug administration. 
However, enzyme activity had not returned to control l evels 24 hours 
after phenyl glyox al. A significant (P < 0. 05) ele va tion in uterine wet 
weight was se en tw o hours after estradiol administration. The initial, 
rapid elevation was followed by a s e cond but less drama t ic one which 
beg an at about 6 hour s after hormone tre a tment. At 24 hours, uterine 
wet we ight was elevated to app roximat e l y 18 0 p e r cent of control. 
Uterine we t we i ght of phenylglyoxal treate d animals did not change 
signific antly (P) 0. 0 5 ) from control values wh en the paramete r was 
measure d ove r the 2 4 hour p eriod following dru g admi nistration 
(Figure 4) . 
H a ving determined the time course of es tr adiol and phenylglyoxal 
activity, it was of interest t o determine whether the g lyo xal s , methyl-
glyoxal and phenylglyoxal, we r e capa ble of alter i ng the e l evation i n 
uterine histone ace t yl ation and wet wei ght which h a d been observed 24 
homsfollowing estradiol tre atment. At 20 hours following e ither 
estradiol v ehide or hormone treatrnent , (es tradiol, 10 p g /r at , 
intraperitoneally) groups of ani1nals rec e ive d either methylglyoxal, 
phenyl glyoxal or a pho spha te b uffe r vehicle . All anirnal s we r e 
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Figu re 4 : Alteration of uter i ne wet \.ve i ght by es tr adio l and phenyl-
glyoxal. Each point r epresents the mean of at l eas t six 
v a lues . Ute rine weight of control animals i s expressed 
as mg wet we i ght. ( 0--0) es tradiol, l 0 p g/ rat, i. p. ; 
( !::r---6. ). phenyl g l yoxal, 2 50 rng / kg , i. p. 
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sacrificed 24 hours following estradiol treatment. Data presented in 
Table 6 indicate that estradiol-17 - ("-> administration causes a rapid 
inc r ease above controls in uterine wet weight (P < 0. 0025) , 24 hours 
following hormone administration . Uterine wet weight did not change 
s ignificantly (P ) 0. 05) fr o m control level when measured 4 hours · 
fo llo wing methylglyoxal administration at either of the doses used in 
this study. Weight of uterine tissue obtained from animals treated 
with estradiol and subsequently with methylglyoxal was elevated above 
that for v e hicle treated controls. Similar results we re obtained with 
phenylglyoxal (Table 7). 
The effect of hormone treatment alone and in combination with 
eithe r methylglyoxal or phenylglyoxal at two dose levels is shown in 
Tables 6 and 7 respe ctively . When measured in vitro follo wing 24 
hour estradiol treatment , enz yme activity was significantly (P( 0 . 0005) 
elevated above control values. Elevation of uterine enzyme activity 24 
hours foJlowing est radiol was more pro nounced in this study than the 
increas e reported in the estradiol time course study. Variation in 
both the age of the animals (25 day old versus 30 day old rats) and 
changes in the brand and preparation of the estradiol solution inay 
account for the ob served differences. 
M e thylglyoxal at both dose leve l s depressed enz yme activity 
when this p arameter was n1casnred 4hours after glyoxal ad1ninistralion 
Table 6. Effect of methylglyoxal treatment on uterine weight and 
his tone acetylation in untr eated and estradiol pre treated 
rats 
44 
Uterine Wet Weight (mg) 
Mean ± S. E. (N} 
E A .. b nzyme ch v1ty 
Treatmenta 
Control 
Est radiol-17- ~ 
Methylglyoxal 
125 mg/kg, i.p. 
M e thylglyoxal 
250 mg/kg, i. p. 
Estradiol plus 
M e thylglyoxal 
125 mg/kg , i. p. 
Es tradiol plus 
Me thylglyoxal 
2?0 mg/kg, i.p. 
a 
104 ± 12 (6) 
1 78 ~ 11 (8) 
(P ~ . 0025) ':< 
98 ± 11 (7) 
(P ) . 05) ,." 
104±11(7} 
(P) .05)':' 
149 ± 11 (7) 
(P ( . 01 )* 
172± 9(8} 
(P( .000 5),;' 
dpm/mg Protein/ 30 min 
Mean± S. E. (N) 
12, 582 ± 1071 (6 ) 
26,209 ~ 3056 (8 ) 
(P < . 0005)* 
8, 033 ± 1291 (7) 
(P( .025) * 
8, 947 ± 877 (7 ) 
(P< .025) * 
5, 022 ~ 693 (7) 
(P < . 0005)>:' 
6,666~ 717(8} 
J, (P < . 0005) ,,-
Control : 0. 2 ml estI·adiol vehicle followed by 1 ml/kg 0. 0 5M phos -
phate buffer (vehicle) , i. p. 20 hrs after ; Estradiol : 0. 2 ml 
(lOµ g}/ rat, i.p; Methylglyoxal: 12 5 mg/kg, i.p . (or 250 mg/kg, 
i. p.) administered 20 hrs follov.ring estradiol vehicle ; Estradiol plus 
Methylglyoxal : es tradiol , 10 p.g /rat, i. p. followed by methylglyoxal 
125 mg/kg , i. p. (or 250 rn.g/kg, i. p. ) 20 hrs after estradiol adminis-
tr ation . All animals \Vere sacrificed 2 4 hrs follo\ving estradiol 
admi nis tr a ti on (4 hrs follo"vi ng me thylgl yoxal administration}. 
bEnzymc acti\rity is expressed as the Mean ±S . E. of the amount (dpm. ) 
of 14 C-acetate incorporated his tone formed p er m.g uterine protein 
(10, 000 x g supe r natant ) per 30 min. 
-·-... 
Detennined by Student "t'' test. 
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Table 7. Effect of phenylglyoxa l treatme nt on uterine weight and 
histone acetylation in untreated and estradiol pretreat e d 
rats 
. a 
Treatment 
Control 
Estradiol-17-0 
Phenylglyoxal 
125 mg/kg , i. p. 
Phenylglyox al 
250 mg/kg, i. p. 
Est radi ol plus 
Phenylglyoxal 
250 mg/kg , i. p. 
Uterine Wet Weight (mg ) 
Mean± S. E. (N) 
104 ~ 12 (6) 
178 ± 11 (8) 
(P< .0025)* 
116 ± 8 (10) 
(P) .0 5)* 
109 = 15 (6 ) 
(P ) . 05) * 
1 77 ± 13 ( 10) 
(P < . 002 5 )* 
Enzyme Activityb 
dpm/mg Prote in/ 30 min 
Mean= S. E. (N) 
12, 582 ± 1071 (6) 
26, 209 ~ 3056 (8) 
(P ( . 0005)>:' 
8,21 5 ± 1153 (10) 
(P < . 0125)* 
7, 123 ± 101 6 (6) 
(P < . 01) * 
7, 638 ± 796 (10 ) 
(P < .0025) >:' 
a 
Control : 0. 2 ml estradiol vehicle followed b y 1 ml/kg 0 . 0 5M phos -
phate buffer (vehicle ), i. p. 20 hrs after; Estradiol: 0. 2 ml 
(10 p g )/ rat , i. p.; Phenylglyoxal : 12 5 mg/kg , i. p. (or 250 mg/kg , 
i. p .) administered 20 hrs following estradiol vehicle ; Estradiol plus 
Phenylglyoxal: e stradiol , 10 p g / rat , i. p. follo we d by phenylglyoxal 
250 mg / kg , i. p., 20 h rs after estradiol administration. All animals 
were sacrificed 24 hrs follo wing estracliol administration (4 hrs 
following phenylglyoxal administration). 
b Enzyme activity is expressed as the Mcan±S. E . of the amount (dpm) 
of 14c-acetate i ncorporated histone fanned per mg uterine protein 
(10, 000 x g supernatant) per 30 min . 
Determine d by Student 11 t" test. 
(Table 6). Similarly, phenylglyoxal treated groups showed lower 
uterine enzyme activity when measured at the 4 hour interval (Table 
7). The glyoxal mediated depression in enzyme activity was also 
apparent in animals who had received estradiol 20 hours prior to 
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either methylglyoxal or phenylglyoxal (Tables 6 and 7). Elevations in 
uterine histone acetylation seen 24 hours following estradiol alone 
were not seen in animals receiving estradiol followed by either 
glyoxal. Drug induced alterations in uterine hi stone acetylation: are 
presented in Figure 5 and 6. 
A dose response comparison of the effects of the glyoxals on 
enzyme activity and uterine wet weight is given in Table 8~ The 
depression of histone acetylation by methylglyoxal and phenylglyoxa l 
administe red at 12 5 mg /kg was not significantly different frorn r esults 
obtained at the 250 mg /kg dose level. Similarly, there was no differ -
ence b etwee n dose level s of either drug on uterine 'vveight of g lyoxal 
treated animals. 
·The data presented in Table 9 indicate that methylglyoxal and 
phenylglyoxal adminis tere d to anirn.a ls pretreated with estradiol for 20 
hours significantly altered the estradio l mediated elevation of uterine 
histone acetylation activity seen at 24 hours in animals r ece iving 
estradiol alone. Neither methylglyoxa l nor phe nylglyoxal significantly 
altered the estradiol inediate d increase in uterine weight. 
47 
130 
120 
100 
80 
;:.... ~ 60 
E-t c Hz A 
::; .:i; 
E-t :r:: 40 Uu 
.:i; E-t 
~z 20 ~~ ;:.... u 
N~ 
z~ 0 ~~ 
20 B c D E 
40 
60 
Figure 5: Alteration of his tone acetylation in rat uterus by 
estradiol and methylglyoxal, expressed as percent 
change from control. Bars r e pre sent mean of at least 
six animals. Drug treated animals received either 
estradi ol and methylglyoxal alone or methylglyoxal 20 
hr. post estradiol. All animals were sacrificed 24 
hrs. following estradiol administration. (A) estradiol; 
10 µg/rat, i. p.; (B) methylglyoxal, 125 mg/kg, i. p.; 
(C) estradiol plus methylglyoxal, 125 mg/kg; (D) 
methyglyoxal, 250 mg/kg; (E) estradiol plus methyl-
glyoxal, 250 mg/kg. 
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Figure 6 : Alteration of hi stone acetylation in ra t uterus by 
estradiol and phenylglyoxal , expressed as percent 
change from control.. Bars represent the mean of at 
least six animals. Drug t realed animals received 
either es tradiol and phenylglyoxal alone or phenyl glyoxal 
20 hrs. post estradiol. All an:irnals were sacrifi ced 24 
hrs. follO\ving estradiol administr a tion . (A ) estradiol, 
10 pg/rat, i. p.; (B) phenylglyoxal, 125 mg/kg , i. p.; 
(C) phenylglyoxal, 250 mg/kg, i. p.; (D) estradiol plus 
phenylgl yoxal , 2 50 mg /kg. 
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Table 8. Cornpari son of alterations in uterine his tone acetylation and 
uterine we t we ight at t wo dose leve ls of rne thylglyoxal and 
phenylglyoxal 
Treatme nta 
Methylglyoxal 
125 mg/kg 
250 mg/kg 
Phenyl gl yoxal 
125 mg/kg 
250 mg/kg 
a 
Uterine Wet Weight (mg ) 
Mean± S. E. (N) 
98 ± 11 
104 ± 11 
(P) . 05) * 
11 6 ± 8 
109 ~ 15 
(P) .0 5)* 
Enzyrn.e Activityb 
dpm/rng Prote in/3 0 m_j_ n 
Mean -: S. E. (N) 
8, 033 ~ 1291 (7) 
8, 94 7 ± 871 (7) 
(P ) . 05) ,:' 
8,215 ~ 115 3 ( 10) 
7, 12 3 ± 101 6 ( 6) 
(P ) . 0 5 )* 
The glyoxals we re adminis te r e d, i. p. 4 hrs prior to sacrifice. 
b 
~~ 
Enzyme activity i s expressed as the Mean ±s. E . of the amount (dpm ) 
of 14c - acetate incorporat e d hi s tone forn~ed p e r rng uterine p ro t e i n 
(10, 000 x g supe r natant ) p e r 30 min. 
D e t e r mine d by Student ' ' t" t es t. 
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Table 9. Effec t of me thylglyoxa l and phenyl g lyoxa l tr eatment on the 
estradiol mediated stimulation of histone acetylation and 
uterine weight. 
Treatmenta 
Es tradiol-1 7 - (? 
Estradiol plus 
Me thylglyoxal 
125 mg/kg, i. p. 
Estradiol plus 
M ethylglyoxal 
250 mg/kg, i. p. 
Est radiol plus 
Phenylglyox al 
250 mg/kg, i. p. 
Uterine We t Weight (mg ) 
Mean± S.E. (N) 
178 ± 11 
149 ~ 11 
(P ) . 05) * 
172 ± 9 
(P).05) * 
177 ± 13 
(P ) . 05 )>:< 
Enzyme Activityb 
dpm/mg Protein/30 min 
Mean± S. E. (N) 
26, 209 ± 3056 (8 ) 
5, 022 ~ 639 (7) 
(P < . 0005) >:< 
6,6 66: 717(8) 
(P < . 00 05 ) * 
..L 
7,6 38:.. 791 (10) 
(P < .0 005)>:< 
a 
Estradiol : O. 2 ml (10 p g )/rat , i. p.; Estra<liol plus M e thylglyoxal: 
estradiol, 10 ng/r at , i. p. foll o wed by met:hylglyoxal , 125 mg/kg , 
i. p. (or 250 mg/kg, i. p.) 20 hrs after estradiol administration; 
Estradiol plus Phenyl glyoxal: estradiol , l Op g/rat, i . p. , followed by 
phenylglyoxal , 250 mg/kg , i. p . 20 hrs after estradiol. All animals 
were sacrificed 24 hrs following estradiol ad1ninistralion (4 hrs 
follo wing administration of either glyoxal) . 
bEnzyme activity i s expressed as the Mean -t S. E . of the amount (dpm ) 
of 14 C - acetatc incorporated his tone forn1e<l per mg utc rine prot e in 
(10, 000 x g supernatant) p er 30 min. 
Dete rnuned by Student 11 t 11 t e st. 
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Table 10 shows the effect of phenylglyoxal, 125 mg/kg, 
administered 4 hours prior to sacrifice, on uterine weight total DNA, 
RNA/DNA ratio and protein/DNA ratio. DNA was employed as a 
baseline in this and parallel studies because, unlike uterine RNA and 
protein, its concentration remains relatively constant during growth 
changes and alterations in hormonal environment. When compared to 
vehicle treated controls, uterine tis sue obtained from animals treated 
for 4 hours v.'1.th phenylglyoxal did not differ significantly in the 
various parameters monitored in this study. 
Uterine wet weight, total DNA, RNA and protein were measured, 
and the uterine/body, RNA/DNA and protein/DNA ratios were deter-
mined in animals treated with phenylglyoxal alone and in combinations 
wilh estradiol. In this study, animals rec eive d phe nyl glyoxal, 125 
mg/kg , intraperitoneally, d a ily for two days. A single inj e ction of 
estradiol, 10 }.lg/rat, intrape rito neally, was administered to rats 
which had received only phosphate buffer vehicle for two days . A 
second group of rats which had rec eived phenylglyoxal for two days 
also received a single inj ection of estradiol. All groups were sacri-
ficed 24 hours following estradiol treatme nt and subsequenl determin-
ation s were performed on the excised uterine .tissu e . The data 
presented in Table 11 indic ate that estradiol given alone e l evated 
uterine wet \veight, where as p henylglyoxal administered for 2 days 
did not significantly alter this parameter. The ute rine '\veight of 
Table 10. Effect of 4 hour phenylglyoxal treatment on wet weight and nucleic acid content in the 
immature rat p.terus 
Ute rine Wet Uterine /Body Total DNA RNA Protein 
--
Weight (mg) R a tio (%) Pooled Uteri (mg) DNA DNA 
<" 
Treatment Mean ± S. E. (N) Mean± S. E. {N ) Mean± S. E. (N) Mean ± S.E. (N) Mean± S.E. (N) 
Control a 53±5(12) 0 . 079 ± . 005 (12) . 94 ± . 07 (5) .508 10. 7 
b 5'4 ':'.: 4 ( 12) 0.082 ± .006 (12) .83 ± .07 (5) . 497 13. 9 Phe nylglyoxal J, 
(P) . 05) :1~ (P ) . 05)* (P ) . 0 5)* (P > . 05)"' (P > . o5t 
a 
Control: vehicle, 1 ml/kg, i. p. of 0. 05M phosphate buffer (pH 7. 4) administered 4 hours prior to 
sacrifice . 
bPhenylglyoxal: dissolved in vehicle and administered 4 h ours prior to sacrifice, 125 mg/kg, i. p. 
,., 
' De ternuned by S tude nt 11 t 11 test. 
\.11 
N 
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Table 11. Effect of 48 hour phenylglyoxal pretreatment on estradiol-
mediated alterations in immature r at uterus 
Treatmenta 
Control 
Estradiol 
Phenylglyoxal 
plus es tr adi ol 
Ute rine Wet Weight (mg ) 
Mean± S. E. (N) 
62 + 12 (12) 
182 "i: 12 (12) 
(P < . 001)* 
98 ~ 7 (10) 
(P < . 005)* 
Ute rus /Body Ratio (%) 
Mean~ S. E. (N) 
. 082 ~ . 009 (12) 
27 ~. 002 (12) 
(P < .001)* 
17~.0l (10) 
(P { . 001)* 
Phenylglyoxal 51 ~ 4 (10) 
(P ) . 05) * 
.092 ~ .0 04 (10) 
(P > . 0 5)* 
a 
Co ntrol : v e}li cle, 1 ml/kg, i. p. of 0. 05M phosphate buffer (pH 7. 4) 
administered once daily for 2 days; Estradiol-17-(?; lOµg/rat, 
i. p. administered 24 hrs prior to sacrifice; Fhenylglyoxal plllS 
E stradiol : 125 mg/kg , i. p. administered daily for 2 days , plus 
estradiol , 10 ).lg/rat , single inj e ction on day 2 of treat1nent. 
Animals were sacrificed 24 hrs following es tradiol; Phenylglyoxal: 
12 5 mg/kg , i. p. administered daily for 2 days . Animals were 
sacrificed 24 hrs following last inj ection 
>:'Determined by Student 11 t 11 test. 
animals pretreated with phenylglyoxal for two days, and then give n 
estradiol was significantly elevated above vehicle treated controls. 
These alterations were also reflected in the uterine/body weight 
ratio. As noted in Table 12, total DNA, RNA/DNA ratio, and 
protein/DNA ratio we re significantly elevated in uterine tis sue 
obtained from estradiol treated animals. Measurement of these 
54 
paran1eters in uterine tissue of phe nylglyoxal treated animals indicate 
that total DNA was not altered, whereas both the RNA/DNA ratio and 
protein/DNA ratio were significantly (P < 0. 005) decreased as 
compare d to vehicle treate d controls. The ute ri of animals pre-
treate d with phenyl glyoxal and then given estradiol contained the same 
total amount of DNA as w as found in vehicle treated controls. 
Howeve r, both the RNA/DNA and protein /DNA ratios we r e elevated 
above control values. In Table 13 a comparison is made between the 
effects of estradiol on the immature rat ute rus and the action of the 
hormone when given to animals who had r eceived phenylglyoxal for 2 
days prior to estradiol ad1ninistration. Uterine we t weight in phenyl-
glyoxal pretreat e d animals was app roximat e ly 50 p e rcent th a t of 
estradiol treated animals. Tota l uterine DNA and the prote i n /DNA 
rati o were significantly (P < 0. 05) decre ased when compared to the 
estradiol t reated group . The uterine RNA/DNA ratio of estradiol 
treated anin1als did not differ fron1 val ues obtaine d fron1 the uterus of 
phenyl gl yoxal pre treated animals r ece iving the hormone . 
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Table 12. Effect of 48 hour phenylglyoxal pretrea tment on estradiol-
medi ated alterations in immature r at uterus 
DNA .(mg) b 
Pooled Uteri RNA/DNA Protein/ DNA 
Treatmenta Mean± S. E. (N) Mean± S. E. (N) Mean± S. E. (N) 
Control 0. 86 ± . 06 (5) 0.600±.016 (5) 11.21±0.65 (5) 
Estradiol 1.21±.09(6) o. 82'5 ± . 039 (6) 18. 30 ± 1. 18 (6) 
(P < . 02)* (P < .001) * (P < . 001) * 
Phenylglyoxal o. 83 ± . 12 (5) 0.831 ± .020 (5) 13.00±0.31 (5) 
. 05) * 
J,. J,. 
plus estradiol (P) (P < . 001) 'I' (P < . 05) -~ 
Phenylglyoxal 0.77 ± .06 (5) 0. 490 ± . 02.0 (5) 7. 78 ± 0. 30 (5 ) 
(P <. • 005) * 
a 
(P > . 05) * (P < .00 5 ) ~~ 
Control: v e hicle , 1 mg /kg , i. p of 0. 05 M phosphate buffer (pH 7. 4) 
administered o nce daily for 2 days; Estradiol-17- ; 10 ug/rat, i. p. 
administe red 24 hrs prior to sacrific e ; Phenylglyoxal plus E s tradiol: 
phcnyl glyoxal , 125 mg/kg , i. p. administered dai ly for 2 days , plus 
estradiol, 10 ug/rat, single inj ec tion o n day 2 of treatment. 
Animals v.:ere sacrificed 24 hrs following estradiol ; Phenylglyoxal: 
125 mg/kg , i. p. adminis t e red o nce daily for 2 days . Anima l s were 
sacrifice d 24 hrs follo wi ng l ast i n j ec tion. 
bRepresents Mean S. E . of tota l DNA content of samples containing 
t wo pooled ute ri. 
De termined by Student "t" tes t. 
Table 13. Effect of 48 hour phenylglyoxal pretreatn1.ent on e stradiol-mediate<l alterations in the 
immature rat uterus : Comparison between hormone treatn1.ent alone and in combination 
with phenylglyoxal. 
Treatmenta 
Estradiol 
Es tradiol plus 
Phenylglyoxal 
Uterine Wet 
Weight (mg) 
Mean± S . E . (N) 
182 ± 12 (12) 
98 ± 7 (10) 
(P < . 001 )>:' 
DNAb 
·--
Pooled Uteri 
Mean -.t S. E . (N) 
1.2 ~ .0 9 (6) 
. 83± . 12(5) 
(P(. 05) * 
RNA 
DNA 
Mean-~ S. E. (N) 
. 825!.039 
. 83 1 ~ . 02 
:1.-(P ) . 05) ,, 
Protein 
DNA 
Mean ± S. E. {N) 
18.3 ± 1.2 
13 . 0±.31 
(P( .00 5t 
aEstradiol -1 7 -(): 10 ug/rat, i.p. administe red 24 hrs prior to sacrifice; Phe.nylglyoxal: 125 mg/kg, 
i. p. administered daily fo r 2 days plus estradiol , 10 p.gh:at, i. p., single injection on day 2 of 
treatment . All animals were sacrificed 24 hrs .following est.radio!. 
bRepresents Mean± S. E . o f total DNA content of samples containing two pooled ute ri. 
*Determined by Student "t" test. 
l11 
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V. DISCUSSION 
The in vitro studies of the effect of various ketoaldehydes on 
uterine histone acetylation suggest a dose dependent inhibitory action 
(Figure 1 ). The nature of the I50 study (Table 1) makes it difficult to 
relate the values for glyoxal concentrations obtained in this study to 
tho se found to be effective in other laboratories. The I50 value is 
dependent upon the protein content used in the system being analyzed, 
in this case, both enzymatic and other cell protein; therefore, the r50 
value s reported in our study will not necessarily correlate with 
similar studies that used a different protein conten t in their assay 
systeni. It is of interest to note , howeve r, that the various glyoxal 
derivatives ernployed in several reported studies (Gregg , 1968; 
Klamerth, 1968; S zent-Gyorgyi, 1968) were active at concentrations 
similar to the I 5o values reported in our studies. Scaife (1969), using 
mM concentrations, obtained methylglyoxal and kethoxal mediated in 
vitro inhibition of human kidney cell DNA, RNA, and protein synthesis . 
Similar conc e ntrations of glyoxal (0. 5mM) are capable of blocking DNA 
replication and protein synthesis w:i thout affec ting respiration in hum.an 
fibroblast cell cultures (Klamerth, 1968). In addition, a sharp con-
centr ation effect , evident in the dose respons e study was reported to 
occur ... vith methylglyoxal when the drug was tested for mitotic inhibitory 
prope rties (Scaife, 1969). While a direct correlation between these 
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literature reports and the present study is not warranted, it is note-
worthy that several studies involving different biological sys terns show 
that glyoxal derivatives are effective at similar concentrations. 
Although inhibition of in vitro his tone acetylation had been 
demonstrated by our previous studies, the mechanism(s) involved in 
thes e actions was left undetermined. Results obtained from the study 
of glyoxal mediated inhibition at the incubation level (Tables 2, 3) 
sug gest that the major site of action is the uterine acetylation enzyme 
system . However, a direct alteration of his tone protein leading to a 
blockade of acetylation must also be considered, since phenylglyoxal-
his tone preincubation results in a significant decrease in the in vitro 
acetylation of histone protein. Takahashi (1968) demonstrated a 
blockade of guanido residues in protein , which may account in part for 
the decrease in his tone acetylation following incub a tion of his tone 
protein in th e presence of phenylglyoxal. 
The results of our in vitro studies led to an analysis of the in 
vivo effects of the glyoxal derivatives. According to present concepts 
of histone function(s), blockade of histone acetylation in vivo might b e 
expected to alter normal growth patterns in a biolo gical systeni. The 
rat uterus , which had been employed during our preliminary studies, 
was chosen as a model system. in which to study glyoxal action , 
becaus e of the \vell defined growth pattern initiated by horm.onal 
stimulation. Although an alleration in uterine histone acetylation 
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following estracliol treatme nt had not been r e ported in the lite rature 
prior to the i nitiation of these studies, it was our b e li e f that hormone 
treatme nt would affect this parameter and th a t hormone-induced 
alterations in the tar ge t organ could b e blocked to some e x t ent by the 
glyoxals. Results obtained from our initial in vivo studies indicated 
that the t w o glyoxals , M e thyl-GAG and glyoxal monohydrate , depressed 
uterine wet weight (Table 4). In additi on, elevation of uterine we t 
w e ight normally observed in estradiol treated rats was not apparent 
in animals receiving estradiol in conjunction wi th the glyoxals (Table 
5). The s e data suggest a glyoxal m ediated blockad e of at l east one 
p arame te r of es trogen r e sponse . 
B e fore any furthe r study involving es tradiol , glyoxals, and 
ute rine histone ace tylation c ould b e attempted, i t was necessary to 
de lineate the action of estradiol on acetyl ation proper ties of the honnone 
stimulated ute ru s , so tha t we woul d then b e able to eval uate glyoxal 
m e diated a lterations of this system more precis e ly. 
An initial effect of es_tradiol treatment on th e rat uterine acetyl-
ation syste1n was the depression of histone acctylation in this organ 
(F i gure 2). This action was very rapid and r esulted in a depression in 
enzyme activity measurabl e as early as 10 ininutes follo"\vi ng hormone 
treatment . Our d a ta are not in agreement wi th Libby ( 1971 ), who 
reported a rapid stimulation of histone acetylation i1nn1ediately follow-
i ng estradiol t reatment , peaking at approxiinatcly 15 minutes and 
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returning to control levels 20 minutes following estradiol treatment. 
However, our results do agree with Anderson and Gorski (1971), who 
demonstrated that es tradiol caused an early dee rease in his tone acetyl-
ation followed by an increase, beginning at about 18 hours and 
elevating to 150 percent of control 24 hours after hormone treatment. 
Kaye and She ratzky ( 196 9) have previously shown a decrease in the 
activity of prote in (histone) methylase obtained from the centrifuged 
(105, 000 x g) supernatant fraction obtained from rat uterus of 
estradiol treated animals. The differences in dose schedule, observa-
tion times, and assay procedure may account for the lack of agreement 
of the results of these studies. 
Phenylglyoxal, 250 mg/kg, intraperitoneally, decrease d enzyme 
activil y when administered one hour prior to estradiol treatment 
(Figure 2). The mean enzyme activity for phenylglyoxal pretreated 
groups r e cci ving es tr adiol tended to be lo'.ve r than the mean value s of 
estradiol treated groups at 0, 5, and 10 minutes follo'vving hormone 
trealrnent. Although not statistically significant (P ) . 05), these 
values suggest that a longer pretreatment p e riod might result in a 
greate r difference between these groups. 
Phenylglyoxal pretreatment, followed by estradiol, significantly 
lowered (P < . 05) hi s tone acetylation activit y as compare d both to 
control groupa and to estradicl treate d groups , \<:hen measured 15 
mi nule s following e stradiol t .reatnl.enl. The apparent ear] y inhibitory 
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effect upon uterine hi stone acetylation by estradiol was unexpected in 
that stimulation of hormonally excitable systems generally results in 
an early augmentation of histone acetylation (Allfrey, 1966; Pogo et al., 
1966; Pogo and Allfrey, 1968). 
Data presented in Figure 3 indicate that one of the initial effects 
mediated by estradiol is a virtually complete inhibition of uterine 
his tone acetylation. The time course of the latter reversal of the 
initial inhibition and subsequent stimulation of his tone acetylation to 
levels above control may be pertinent when estrogen mediated alter-
ations in uterine RNA and protein content are considered . In the 
studies of Olive r and Kellis ( 1970), RNA (J.lg /mg dry weight ) in the 
irnma tur e rat uterus remained r e lative ly constant up to 10 hours after 
treatment with 5 pg of estradiol. Elevation of uterine RNA l eve ls 
r e portedly occurred between 10 and 12 hours following estradiol , 
whereas uterine DNA (ug/mg dry weight) decreased during the same 
interval . Administration of estradi ol to ovariectomized rats resulted 
in a measurable elevation i n the RNA/DNA r atio , con~menci.ng 
approxirnate ly 8 hours and continuing up to 24 hours after hormone 
administration. Results of the present study suggest that t he 
estradiol mediated elevation in ute rine his tone acetylation occurred at 
a ti1ne when uterine RNA l eve l s were increasing through the action of 
this hormone . These findings are in accord \.vith othe r workers \.vho 
h ave obs e rved an e l evation in his tone acetylation preceding or 
paralleling rises in RNA and protein in several unrelated syste1ns 
(Allfrey. et al., 1963; Pogo~ al., 1966; Pogo et al., 1969). 
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Measurement of uterine histone acetylation activity following 
phenylglyoxal treatment (Figure 3) demonstrated the ability of this drug 
to cause a rapid depression in uterine enzyme activity, with peak 
depression corresponding to approximately 60 percent inhibition 4 
hours followi ng phenylglyox al administration. Enzyme activity 
remaine d depressed up to 24 hours. The effect of both estradiol and 
phenylglyoxal on uterine hi stone ace tylation and alterations in ute rine 
wet weight followe d similar temporal patte rns during the first 2 hours 
of drug activity (Figure 4). 
The appa r e nt decrease in ute rine we t weight follow ing phenyl-
glyoxal tre atment was not significant (Figure 4), although it is assumed 
from the r esults presented in Table 1 tha t m ore p ro longed adminis -
tration of phe nylglyoxal would most like ly depress uterine we t weight. 
The rapid e l evation in uterine wet weigh t following estradiol adrninis -
tration to i mmature female r a ts is well charac t erized , _and it is thought 
to b e primarily a hype rtrophic r esponse . Water uptake in the uterus 
of estradiol t reated rats r eaches a peak 4 to 6 hours after hormone 
treat men t. The initial water inhibition was followed by a second 
similar r esponse after 12 h ours {Mueller , 1971). Uterine we t weight , 
measure d 2 4 hours afte r hormone administration to ovari e ctomi zcd 
r a ts, h as b een shown to i ncrease appr o ximately 190 p e rcent above 
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untreated controls (Hamilton~ al., 1968). In our study, uterine wet 
weight alterations seen in 25-30 day old female rats following 
estradiol treatment were sirnilar to those previously reporte d (Figure 
4). The physiological effects characte ristic of estradiol we re evident 
throughout the period uterine his tone acetylation was monitored. It is 
difficult at this time to pre sent a complete ly satisfactory explanation 
of the biological role this hormone plays in its initial action on hi stone 
acetylation in its target organ. Barker (1971) showed that the 
synthesis of arginine -rich his tones in rat uterus following estradiol 
treatment was elevated immediat e ly. The rate of synthesis dee r eased 
tow ard control l evels 6 hours after treatment and then b ecame 
ste adily e l e vate d to a 22-fold in c reas e 48 hours following estradiol. 
Surprisingly, the amount of arginine-rich histone p er ute rus decreased 
dr amatically to 44 p ercent of control l eve ls 1 hour follo wing es tradiol 
administr ati on, r emaining depressed until appr oximate ly 10 hours 
afte r estradiol when it returned to control levels; a nd then when 
measured 12 hours following hormone t reatment , the y b~came 
elevated to 13 8 p ercent of con t ro l values. Estradiol mediated altera-
tio ns i n uterine h is tone synthesi s and content observed in these studies 
som.ewhat p a ralleled the pattern of alte r atio ns i n hi s t one acclylation 
r eported in our work . 
These results m ay offe r an explanation of some of the alterations 
ob se r ved following estradiol adm.inistration. Barker (1 97 1) suggests 
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that hydrolysis of his tone protein may account for its disappearance 
in the uterus immediately following estradiol treatment. Paik and 
Lee (1970; 1971) have reported an enzyme which specifically 
hydrolyzes histone protein. Earlier, Goodall (1965) reported an 
increase in uterine proteolytic a.cti vity following es tradiol adminis -
tration. We suggest that, if such an enzyme exists in the uterus, the 
elevation of its activity by estradiol, either through activation mech-
anisms or through de novo synthesis, would account for the rapid 
depression in arginine-rich histone content in the estradiol treated 
uterus. Control mechanisms involved in the depression of his tone 
content by the hormone might also be responsible for a decrease in the 
activity of an enzyme involved in the control of his tone modification. 
Any continuation of the normal cellular levels of uterine his tone 
acetylation in the face of rapidly decreasing his tone levels following 
estradiol would not be efficient, whereas a corresponding decrease in 
enzyme activity to parallel the depleted uterine histone content would 
be reasonable. As the highly elevated rate of hi stone synthesis 
negated the effect of elevated his tone degradation, normal histone 
levels would be reestablished and a "feedback" type of control of 
hormonal stirnulation would be accorn.plished. A return of uterine 
his tone acetylation capacity foll0wing e stradiol would be expected to 
follow the observed rise in his tone content, since histone modification 
would again b e re qui red. 
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Barker 1 s observation that the levels of uterine arginine -rich 
histones were elevated to above control values 12 hours after estradiol 
coupled with our findings that such elevation precedes the reversal in 
the initial depression in his tone acetylation, are consistent with this 
proposed model of estradiol mediated alterations in his tone metab-
olism. We suggest that an alteration in histone metapolism other 
than by acetylation may be implicated in the initial de repression 
mechanisms thought to occur in the estradiol stimulated rat uterus. 
Our previous study established that estradiol elevates uterine 
his tone acetylation when measured 24 hours following hormone 
treatment. Furthermore, phenylglyoxal depressed this parameter 
with peak depression in activity occurring 4 hours following drug 
administration. By aligning these time intervals, it was possible to 
measure the effect of glyoxal treatment on the established elevation of 
uterine histone acetylation 24 hours after hormone treatinent. 
Uterine wet weight was utilized as a secondary measurable parameter 
to monitor the net physiological action of e stradiol and phenylglyoxal. 
The data obtained from this study suggest that 4 hour treatment with 
either rn.ethylglyoxal or phenylglyoxal is ineffective in itself in altering 
uterine wet weight significantly (Tables 6, 7). Similarly, the 
elevations in uterine wet weight in estradiol treated animals receiving 
phenylglyoxal or methylglyoxal suggest that the glyoxals do not reverse 
the initial uterine hypertrophy following horm.one treatment manifest 
at the time of glyoxal administration. These data are consistent with 
the view that early water imbibition of the uterus, which accounts for 
most of the elevated uterine wet weight following estradiol, is an 
extragenomic action of the hormone. Ui and Mueller (1963) have 
shown that water imbibition of the uterus following estradiol takes 
place even when uterine RNA synthesis has been blocl~ed by actino-
mycin-D; their findings support the contention that the process of 
uterine imbibition is not completely under genornic control. It is 
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the ref ore conceivable that the depression of uterine hi stone acetylation 
activity by methylglyoxal and phenylglyoxal treatment or the apparent 
reversal of the estradiol mediated elevation in enzyme activity (Table s 
6, 7; Figures 5, 6) might not be expected to influence all n~easurable 
parame ters in the ute rus in a paralle l manne r. 
An analysis of uterine tissue obtained from phenylglyoxal treate d 
animals 4 hours after drug administ ration failed to show any alteration 
in the parame t e rs monitored in this study (Table 10). Since uterine 
histone acetylation is depressed by this treatment , it is evident that the 
depresse d enzyme activity precedes any measurable alteration in 
nucle ic acids and prote in content , as refle cted by the total DNA, 
RNA/DNA and protein /DNA ratios. Pogo~ al. (1966) reported that 
RNA synthesis in equine polymorphonuclear l euc ocytes following treat-
ment with phytohemaglutinin in vitro was diminished. Furthe rmore, 
preliminary experiments suggest that an inhibition of histone acetylation 
/! 
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in this system may precede the observed decrease in RNA synthesis. 
Since we have measured levels rather than synthesis of uterine 
nucleic acids follo'vving 4 hours glyoxal treatment, it was not unex-
-
pected that little or no alteration in nucleic acid content following 
short term glyoxal treatment was noted. However, by extending the 
period of glyoxal treatment from 4 to 48 hours, it was_ possible to 
demonstrate a more pronounced effect of phenylglyoxal on the uterus 
of e stradiol treated animals. Although phenylglyoxal does not lower 
uterine wet weight when given alone, the drug is capable ·of dee reasing 
the magnitude of uterine weight gain seen after administration of the 
hormone (Table 11). This action is significant in that it demonstrates 
the ability of an endogenous metabolite to interfere with the physic-
logical action of a steroid hormone. Alterations of nucleic acid and 
protein constituents of the estrogen stimulated uterus become 
apparent when measured in phenylglyoxal pretreated animals receiving 
the hormone (Table 12). Elevations in total uterine DNA and the 
protein/DNA ratio following e stradiol are not attained in phenylglyoxal 
pretreated animals (Table 13). Phenylglyoxal apparently does not 
affect the estrogen mediated elevation of the DNA/RNA ratio. These 
data are in general agreement 'vvith other studie s concerned with the 
action of the glyoxals in various biological systems. In studies using 
human kidney cells, Scaife (1969) found that kethoxal and m e thyl-
glyoxal were potent inhibitors of protein synthesis in this system; DNA 
synthesis was partially blocked, whereas RNA synthesis was only 
slightly influenced. A similar pattern of glyoxal mediated alterations 
in DNA, RNA and protein synthesis has been described by Szent-
Gyorgyi. ( 196 7). Klame rth (1968) has also reported that the principal 
effect of glyoxal (0. 5mM) on human cells grown in culture is a 
depression in both DNA and protein synthesis, leading him to believe 
that DNA replication rather than transcription is being blocked by the 
glyoxals. 
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In light of the results presented here and in related studies, the 
possible consequences of glyoxal mediated inhibition of the acetylation 
of hi stones involved in the control of DNA replication warrant con-
sideration if a mechanism of action is to be determined for the known 
biological activity of the ketoaldehydes. If the ketoaldehyde s are 
important agents in the regulation of hi stone acetylation, this suggests 
that they may be therapeutically useful in inducing a termination of 
cellular pro life ration. 
• • f -
VI. SUMMARY AND CONCLUSIONS 
The ke toaldehydes, phenylglyoxal and methylglyoxal, inhibit the 
in vitro acetylation of his tones by a cell-free soluble fraction of rat 
uterus. The degree of enzyme inhibition is dose related. As deter-
mined by the reported I 50 value for each drug, methylglyoxal and 
phenylglyoxal are equally effective in inhibiting his tone acetylation. 
In vitro inhibition of uterine histone acetylation by phenylglyoxal 
is thought to be accomplished primarily by inhibition of the uterine 
enzyme system. However, the formation of a glyoxal-histone complex 
which is a product less capable of undergoing acetylation is also 
suggested by our data. The importance of these actions in vivo cannot 
be assessed at this time. 
Immature female rats treated for six days with glyoxal mono-
hydrate gain less weight than vehicle treated controls, whereas 
Methyl-GAG had no effect on this pararneter. The decrease in uterine 
wet weight following glyoxal treatment was not as evidence in Methyl-
GAG treated rats. Estradiol mediated elevations in uterine /body ratios 
are blocked or reversed by prior treatment with Methyl-GAG and 
glyoxal monohydrate, respectively. Uterine /body weight ratios but 
not liver/body weight ratios were altered when rn.e asured in animals 
receiving the glyoxals and estradiol. 
The hormonally stimulated immature rat uterus was develope d 
as a model system in which to measure estradiol and ketoaldehyde 
induced alterations in uterine his tone acetylation. Various para-
meters were monitored in order to delineate more clearly the 
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actions of both the glyoxals and estradiol on the physiology and bio-
chemistry of the system under study. The temporal relationships of 
the alterations induced by these agents may offer an alternate explan-
ation for the biological action of both the hormone anc! the propos ed 
inhibitor. 
A rapid depression in uterine his tone acetylation occur red 
following estradiol administration to immature rats. The initial 
hormonal action on uterine his tone acetylation was reversed over the 
initial 24 hours, leading to an elevation above control levels. The 
depression in utc rine hi stone acetylation occur red during the period in 
which hormonally induced elevati o ns in uterine wet weight were 
obs erved. These findings suggest that an elevation in hi stone acetyl-
ation may not be an initial event in the general stimulation of the 
immature uterus by estradiol. 
Four hour tr eatment with methylglyoxal and phenylglyoxal 
reversed the estradiol mediated elevation in uterine his tone acetylation, 
without affecting uterine wet weight. The phenylglyoxal mediated 
inhibition of uterine his tone acetylation preceded any alteration in 
uterine wet weight , total DNA, RNA/DNA or protein/DNA ratio. 
When the duration of phenylglyoxal treatment was extended to 
48 hours in order to measure the effectiveness of the drug in altering 
,. . 
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the actions of estradiol on various parameters of the model system 
under study, depressions in uterine RNA/DNA and protein/DNA 
ratios occurred. Estradiol-mediated elevations in uterine wet weight, 
total DNA and the protein/DNA ratio were partially blocked by this 
treatment. The drug was ineffective in blocking the elevation in 
RNA/DNA ratio produced by estradiol. The alteration of normal 
physiological activity in the immature rat uterus by phenylglyoxal 
became most apparent when this action was monitored in a hormonally 
activated system. 
Although no direct correlation between the initially depressed 
rate of hi stone acetylation preceding the decrease of uterine nucleic 
acid levels can be made, we suggest that blockade of the normal 
pattern of histone modification following hormone adn1inistration may 
lead to parallel depressions in levels of key intermediates necessary 
for the complete accornplishment of hormonal action. 
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The data presented in this appendix is complementary in nature 
and serves to more clearly characterize the uterine histone acetyl-
ation system employed in this study. 
Significant h~stone acetylation activity was observed in the mito-
chondrial, microsomal and supernatant (100, 000 x g) -fraction of rat 
uterus obtained from immature (25 day old) rats. Specific activities of 
16, 255, 31, 219 and 157, 563 DPM/mg protein were observed for these 
fractions, respectively {Appendix A). These data, expr~ s sed as 
percent total activity versus percent total protein is represented in 
Appendix B. Enzyme activity was highest in the soluble (supernatant) 
rat uterus fraction. 
The effect of temperature on in vitro his tone acetylation is 
represented in Appendix C. Enzyme activity remains constant from 
0 0 rl:Jr. 30 c to 38 c followed by an abrupt el.evation at 4u-~ assay temperature. 
Enzyme activity decline d sharply as the temperature exceeded 40°C 
and approache d 60°C. The 0 10 (37-45°C) value of the acetylating 
enzyme system is 1. 77. 
0 
The elevation in histone ac e tylation activity at 40 C was used as 
a basis for studying reversibility of this activity. Enzyme preparations 
preincubate d at an elevated tempe rature (40°C) retained their elevated 
acetylation activity when assaye d at the standard incubation temper -
ature of 37°c {Appe ndix D). Enzyme pr e parations containing equal 
aliquots of enzyme preincubated at 37°C and at 40°C demonstrated 
activity slightly less than additive 
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APPENDIX A 
Subcellular Localization and Specific Activity of Histone Acetylation 
In Immature Rat Uterus 
Specific Activity Percent of 
Fractiona (dpm/mg protein) Total Activity 
Nuclei 4,610 2.2 
Mitochondria 16,255 7.8 
Microsomes 31,219 14.8 
Supernatant 157,563 75.2 
(105, 000 x g) 
aA weighed sample of rat uterus was homogenized in 
0. 25M sucrose and centrifuged at 780 x g for 15 
minutes, and 105, 000 x g for 60 minutes to obtain 
nuclear, mitochondrial, and microsomal pellets, 
respectively. Pellets we re washed in 0. 25M sucrose and 
resuspended to volume in Robinson's media (Robinson, 
1949). A 0. 05 ml aliquot of each fraction was used as 
enzyme source fo"r assay of his tone acetylation. 
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APPENDIX B 
Subcellular Localization and Spe cific Activity of Hi stone Acetylation 
In Immature Rat Uterus 
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APPENDIX C 
Effect of Temperature on i:h vitro His tone Acetylation 
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APPENDIX D 
In vitro Thermal Activation of His tone Acetylation Properties of 
Rat Uterine Supernatant Fraction 
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Hi stone 
Acetylation 
Preincubation Assay {dpm/mg Histone) 
Series Temperature Temperature Mean"!: S. E. * 
Ia 37°c 37°c 13, 793 ~ 1885 
_nb 40°c 37°c 26,313 ~ 2680 
IIIC 37°c 37°c 18,220 ~ 1115 
400C 
aStandard assay system using 10, 000 x g rat uterine fraction (0. 1 ml) 
preincubated for 20 min at 37°C, cooled on ice and added to complete 
assay system for incubation at 37°c for an additional 15 min. Prior 
to incubation, uterine fraction was diluted (1:1) with Robinson's media. 
bStandard assay system using 10, 000 x g rat uterine fraction (0. 1 ml) 
preincubated for 20 min at 40°C, cooled on ice and added to complete 
as say system for incubation at 37°c for an additional 15 min. 
Uterine fraction was diluted (1:1) as above. 
cStandard assay system using combined supernatant fraction prepared 
by mixing O. 1 ml aliquots of undiluted Series I and II treated super-
natant with O. 2 ml Robinson's media . At time of assay, 0. 1 ml of 
final mixture was added to complete assay system for incubation at 
37°c for 15 min. 
*Mean~ S. E. (for three determinations). 
